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8INTRODUCTION
Bacterial virulence defines the strength of the pathogenic potential of a microorganism.
Several bacterial virulence factors and mechanisms contribute to this potential to cause disease.
Actinobacillus actinomycetemcomitans, a pathogen not only in periodontal but also in some
nonoral infections, possesses several virulence determinants which contribute to its ability to
colonize the oral cavity, persist in the periodontal pocket, resist and evade host defenses, cause
destruction to soft and hard tooth-supporting tissues, and interfere with host tissue repair after
infection (Fives-Taylor et al. 1999).
A. actinomycetemcomitans is one of the most thoroughly studied periodontal bacteria.
Previous studies on A. actinomycetemcomitans have been performed mostly on oral
serotypeable A. actinomycetemcomitans strains. More information is needed on
nonserotypeable A. actinomycetemcomitans strains and A. actinomycetemcomitans strains from
nonoral infections, since they may exert virulence different from that of serotypeable and/or
oral A. actinomycetemcomitans strains. Some virulence factors of a few A.
actinomycetemcomitans laboratory strains have been closely studied. New data are required as
to the expression capacity of specific virulence factors in clinical A. actinomycetemcomitans
strains and the effects of this expression on the host. We would then better understand the
pathogenic potential and mechanisms exerted by this organism and understand its contribution
to periodontal destruction.
The hypothesis of the present studies was that differences exist in the virulence
characteristics among A. actinomycetemcomitans clones. The aim was to find A.
actinomycetemcomitans strains with elevated virulence by studying the reasons for the
nonserotypeability of A. actinomycetemcomitans strains, by phenotypically and genotypically
characterizing nonoral A. actinomycetemcomitans strains, and by studying the heat-response, a
probable virulence factor, of A. actinomycetemcomitans and its effects on periodontal epithelial
cells.
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Periodontal diseases
Periodontal diseases are inflammatory changes in the periodontium caused by bacterial
infection. Gingivitis leads to bleeding, swelling, and redness of the marginal gingiva.
Periodontitis leads to destruction of the tooth-supporting tissues, both connective tissue and
bone, and eventually to tooth loss. The various forms of periodontal diseases differ from each
other in etiology, natural history, and response to therapy, but exhibit similar clinical and
histopathological events (Page & Schroeder 1977).
Pathogenesis
The general principles in the pathogenesis of periodontitis established by Page &
Schroeder (1976) are still currently accepted, and continuing research since then has added
detailed information to elucidate the entire picture of periodontal pathogenesis (American
Academy of Periodontology 1992, World Workshop in Periodontics 1996, Page & Kornman
1997). The pathogenesis of the periodontal lesion occurs in initial, early, established, and
advanced stages, of which the first three are characterized as gingivitis and the last as
periodontitis (Page & Schroeder 1976). In initial and early stages, accumulation of dental
plaque in the gingival sulcus enhances the leukocyte and neutrophil migration to the junctional
epithelium and underlying connective tissue, results in loss of collagen and fibroblast alteration
in the marginal gingiva, and induces the proliferation of basal cells of the junctional epithelium
(Page & Schroeder 1977, Schroeder 1996). Later, in the established lesion, plasma cells
predominate, the connective tissue loss continues, and the junctional epithelium migrates
apically starting conversion to pocket epithelium (Page & Schroeder 1977, Zappa 1995).
Destruction of alveolar bone and connective tissue in the gingiva and periodontal ligament,
periodontal pocket formation, and several inflammatory reactions take place in the advanced
periodontal lesion (Page & Schroeder 1977). Bacteria are etiological agents, but they are not
alone responsible for the tissue destruction in periodontitis. Most of the periodontal tissue
destruction is due to indirect activity of bacteria: activation of protective and defensive host
mechanisms, such as enzymes and cytokines, can lead to destruction of the host tissues
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(Kornman et al. 1997). In the initiation and progression of periodontitis the susceptibility of the
host to disease is not yet completely understood. Genetic and environmental factors, including
compromised immunity, smoking, and hormonal factors, are suggested to be risk factors for
periodontal diseases (American Academy of Periodontology 1992, World Workshop in
Periodontics 1996, Page et al. 1997).
Bacteriology of periodontal infections
More than 500 cultivable bacterial species have been isolated from the gingival crevices
of human beings (Moore & Moore 1994), but the actual species count may be thousands, since
a wide proportion of bacteria remains unculturable or unidentified (Socransky et al. 1987,
Wilson et al. 1997). The subgingival bacterial flora consists of facultatively anaerobic gram-
positive species in the healthy oral cavity, but in gingivitis the proportion of gram-negative
bacteria increases (van Palenstein Helderman 1981). In periodontitis, only 10 to 30 species,
mainly gram-negative anaerobic bacteria, are putative pathogens (Socransky & Haffajee 1994).
Three species, Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and
Bacteroides forsythus, are presently considered periodontal pathogens and primary etiological
agents in periodontitis (World Workshop in Periodontics 1996). Additional putative
periodontal pathogens include Prevotella intermedia, Prevotella nigrescens, Campylobacter
rectus, Fusobacterium nucleatum, Peptostreptococcus micros, and spirochetes (American
Academy of Periodontology 1992, Haffajee & Socransky 1994, World Workshop in
Periodontics 1996).
Characteristics of Actinobacillus actinomycetemcomitans
A. actinomycetemcomitans was first described in 1912 (Klinger 1912) as Bacterium
actinomycetem comitans, "a bacterium associated with actinomyces."
General characteristics
A. actinomycetemcomitans is a gram-negative nonmotile coccobacillus. The organism is
facultatively anaerobic and capnophilic; it grows well in 5% CO2 in air or anaerobically, and
growth into well-developed colonies takes 48 to 72 h (Slots 1982a). A.
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actinomycetemcomitans does not require X (hemin) or V (nicotinamide adenine dinucleotide)
factors for growth (Slots 1982a) and grows in the absence of serum or blood (Tsai et al. 1979).
Biochemically, A. actinomycetemcomitans is nonhemolytic, produces catalase, does not
produce indole, reduces nitrate, and is fermentative (Hammond & Stevens 1982, Slots 1982a).
On solid growth media, fresh A. actinomycetemcomitans isolates adhere to agar and form
circular colonies, 0.5 to 1 mm in diameter, with slightly irregular edges (Slots 1982a). These
phenotypically rough colonies are translucent, with an internal star-shaped morphology (Slots
1982a). Fimbriae on the cell-surfaces make rough A. actinomycetemcomitans colonies adherent
to agar (Scannapieco et al. 1987, Rosan et al. 1988). After repeated subcultures, the internal
structure of the bacterial colonies may be lost, forming smooth colony types with more opaque
colonies, as represented by A. actinomycetemcomitans strains from the American Type Culture
Collection (Slots 1982a). A conversion has been observed: from a fimbriated rough phenotype
to non-fimbriated smooth phenotype with decreased ability to adhere (Slots 1982a, Rosan et al.
1988, Inouye et al. 1990, Haase et al. 1999).
A. actinomycetemcomitans in the oral cavity and as a periodontal pathogen
The oral cavity is the ecological niche for A. actinomycetemcomitans. Approximately
90% of patients with localized juvenile periodontitis (LJP) and 50% of adult periodontitis
patients harbor A. actinomycetemcomitans in the oral cavity (Slots et al. 1980a), and this
organism may be isolated from some periodontally healthy subjects as well (Slots et al. 1980a,
Asikainen et al. 1986). However, A. actinomycetemcomitans has not been detected in
edentulous infants (Könönen et al. 1992). A. actinomycetemcomitans was first isolated and
identified to species level in human periodontal lesions in 1979 from a patient with juvenile
periodontitis (Baehni et al. 1979). Nearly two decades later, in 1996, it was classified as a
periodontal pathogen (World Workshop in Periodontics 1996). This organism fulfills the
criteria of an etiological agent of periodontitis (Socransky 1979). A. actinomycetemcomitans is
present in high numbers in periodontal lesions, especially in LJP, and absent or in low
proportions in healthy periodontium (Slots et al. 1980a, Zambon 1985, Asikainen et al. 1986).
The elimination of the organism results in improvement of the clinical periodontal condition
(van Winkelhoff et al. 1992). The host with a periodontal infection exhibits elevated serum and
salivary antibody levels against this pathogen (Ebersole et al. 1982). A. actinomycetemcomitans
possesses virulence factors associated with the pathogenesis and the progression of the disease
(Baehni et al. 1979, Kiley & Holt 1980, Shenker et al. 1982, Wilson & Henderson 1995).
12
Additionally, animal models link the organism to periodontal tissue destruction (Irving et al.
1975).
A. actinomycetemcomitans in systemic infections
Besides periodontal infections, A. actinomycetemcomitans is occasionally isolated from
severe systemic infections (for reviews see Zambon 1985, van Winkelhoff & Slots 1999). It has
been detected, either as a causative agent or as a co-pathogen, from native- or prosthetic-valve
endocarditis (Pierce et al. 1984, Kristinsson et al. 1988, Kaplan et al. 1989, Verhaaren et al.
1989, Braconier & Söderström 1990, Chen et al. 1991, el Khizzi et al. 1997), pericarditis
(Horowitz et al. 1987, Zijlstra et al. 1992), septicemia (van Winkelhoff et al. 1993), pneumonia
(Morris & Sewell 1994, Yuan et al. 1992), infectious arthritis (Molina et al. 1994), and
abscesses in various body sites, such as brain, submandibular space, or hand (Salman et al.
1986, Kaplan et al. 1989, Zijlstra et al. 1992). The majority of reported nonoral A.
actinomycetemcomitans infections are case reports, and the information on the microbiological
characteristics of nonoral A. actinomycetemcomitans strains is limited.
Approximately 0.6% of infective endocarditis cases are estimated to be caused by A.
actinomycetemcomitans (Das et al. 1997). The true number of nonoral A.
actinomycetemcomitans infections may be higher, since the organism may be difficult to grow
and identify in most laboratories, and therefore may remain unrecognized or be misidentified
(Morello 1980, Das et al. 1997). Recently, periodontitis has been associated with chronic
coronary heart disease (Mattila et al. 1995, Beck et al. 1996), and A. actinomycetemcomitans
has been identified in atheromatous plaques in coronary arteries (Zambon et al. 1997). Besides
the classic coronary risk factors, periodontal pathogens may play a role in the pathogenesis of
coronary heart disease (Mattila et al. 1998).
Serotype classification of A. actinomycetemcomitans
Several techniques, such as immunodiffusion (Zambon et al. 1983, Saarela et al. 1992)
and indirect immunofluorescence (Zambon et al. 1983, Asikainen et al. 1991) with polyclonal
antibodies, or indirect immunofluorescence with monoclonal antibodies (Gmür et al. 1993),
have been carried out to serologically characterize A. actinomycetemcomitans. Up to now, five
A. actinomycetemcomitans serotypes have been designated (a, b, c, d, and e) (Zambon et al.
1983, Saarela et al. 1992). However, 3% to 8% of A. actinomycetemcomitans isolates remain
nonserotypeable (Saarela et al. 1992, Gmür et al. 1993, Poulsen et al. 1994). Most periodontal
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patients with A. actinomycetemcomitans infections harbor only one serotype (Slots et al. 1982,
Zambon et al. 1983, Saarela et al. 1992, Dogan et al. 1999a). Multiple serotypes (or
serotypeable and nonserotypeable isolates) are found in less than 10% of the subjects (Saarela
et al. 1992, 1999). The serotype distribution of A. actinomycetemcomitans in the oral cavities
of periodontal patients seems to be heterogeneous: serotype a in 25%, b in 29%, c in 23 to
26%, d in 3 to 4%, e in 6 to 10%, and nonserotypeable isolates in 3 to 5% of subjects (Saarela
et al. 1992, Dogan et al. 1999a). The only study on the A. actinomycetemcomitans serotype
distribution in nonoral infections suggested the predominance of serotype c in 72% of subjects
(Zambon et al. 1988). After the study of Zambon and coworkers (1988), two novel A.
actinomycetemcomitans serotypes, serotypes d and e, were found (Saarela et al. 1992, Gmür et
al. 1993). Studies on serotype distribution of nonoral A. actinomycetemcomitans strains which
take these two new serotypes into consideration have not been carried out.
Genotype classification of A. actinomycetemcomitans
Molecular typing techniques, including restriction endonuclease analysis (Zambon et al.
1990, van Steenbergen et al. 1994), restriction fragment-length polymorphism (DiRienzo et al.
1990, Slots et al. 1993), the arbitrarily primed polymerase chain reaction (AP-PCR) (Slots et
al. 1993, Asikainen et al. 1995), and ribotyping (Alaluusua et al. 1993, van Steenbergen et al.
1994), have been used to genotypically characterize A. actinomycetemcomitans isolates. Of
these methods, ribotyping has produced the most heterogenic variety of genotypes, but is the
most time-consuming and laborious technique. AP-PCR distinguishes approximately 20 A.
actinomycetemcomitans genotypes, the amount depending on the primers used, and is a rapid
and simple technique. A. actinomycetemcomitans isolates of a given AP-PCR genotype usually
belong to the same serotype (Asikainen et al. 1995), indicating a systematic genetic
dissimilarity between serotypes. Additionally, ribotyping (Saarela et al. 1995) and restriction
endonuclease analysis (Zambon et al. 1990, van Steenbergen et al. 1994) show the serotype-
specificity of certain A. actinomycetemcomitans clones.
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Background of host-pathogen interaction
Host defense
Against bacterial pathogens each host exhibits non-specific and specific defense
mechanisms (Male & Roitt 1998). The non-specific host defense mechanisms, such as intact
skin and mucosa, the cleansing effect of body fluids or ciliary action, and phagocytes in tissues
and blood, are always present and aimed against all pathogens. The specific host defense by
humoral and cellular immunity, including antibodies, activated macrophages, and cytotoxic T
cells, is directed towards a specific target and induced after the appearance of the target. The
colonization of pathogenic flora is made difficult in the skin, oral cavity, upper respiratory tract,
colon, and vagina by the resident commensal microbiota, which are generally non-pathogenic in
their natural habitat. However, the presence of commensal bacteria in severe infections is not
rare; 63% of infective endocarditis episodes are caused by streptococci (Bayliss et al. 1983), of
which oral “viridans streptococci“ represent 50% of cases (Knox & Hunter 1991).
When interacting with the host, the pathogen first comes into contact with the epithelial
cells lining the mucosal surfaces of the oral cavity or respiratory, intestinal, or genitourinary
tracts. Besides functioning as a barrier against exogenous invaders, the epithelial cells sense the
microbial infection and provide signals to the host, transmit information between epithelial cells
and the cells in the underlying connective tissue, and activate a wide range of inflammatory and
immune responses (Kagnoff & Eckmann 1997). The response of intestinal epithelial cells to
enteric bacteria depends on the invasion capability of the bacteria (Kagnoff & Eckmann 1997).
For instance, Salmonella, Yersinia, Shigella, and Listeria, species that penetrate the epithelium
and invade the gut mucosa, induce a rapid expression of inflammatory cytokines in epithelial
cells. Clamydia, which invades cervical and intestinal epithelial cells but not the underlying
mucosa, initiates a delayed inflammatory response by directly activating the epithelial cells.
Many of the epithelial-cell responses evoked by bacteria contribute to epithelial-cell growth,
development, and death (Kagnoff & Eckmann 1997, Zychlinsky & Sansonetti 1997).
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Bacterial virulence
Pathogenicity is defined as the ability of a microbe to produce disease and cause
damage in the host (Salyers & Whitt 1994). Virulence determines the strength of the
pathogenic potential and defines the relative capacity of a microbe to cause damage in the host
and its ability to overcome host defenses (Casadevall & Pirofski 1999). Virulence includes
invasiveness, tissue-destructive capacity, and evasion of host responses. These characteristics
are individual to each pathogen. Recently, degree of host damage has been suggested as a
means of characterizing microbial pathogenicity (Casadevall & Pirofski 1999).
The susceptibility of the host plays a role in infectious diseases. Pathogens that cause
disease in some people may be harmless colonizers in others. Approximately 80% of the
exposed population may carry Neisseria meningitidis in their noses or throats during a
meningitis outbreak, but only a small proportion develop the disease (Salyers & Whitt 1994).
Additionally, clonal diversity within species may contribute to the outcome of the disease. For
instance, Escherichia coli strains causing gastrointestinal infections will not cause urinary tract
infections or meningitis, because the strains have a different pathogenic potential to cause
disease in different host tissues (Salyers & Whitt 1994, Falkow 1997).
The host environment regulates the expression of bacterial virulence genes (Guiney
1997). During the course of an infection, the temperature, pH, osmotic strength, and oxygen
and iron availabilities in the growth environment may change dramatically, requiring bacterial
adaptation to the new environment (Guiney 1997, Falkow 1997). Temperature-sensitive gene
expression, needed for instance in the invasion of colonic epithelium by Shigella, does not take
place at the normal temperature but is induced at elevated temperatures (Hale 1991). However,
some genes responsible for cellular processes under normal conditions may, in addition, take
part in bacterial survival during stressful conditions. For example, diadenosine tetraphosphate,
encoded by the apaH gene, controls the timing of cell division in E. coli (Nishimura et al.
1997) and also signals the heat and oxidative stress responses of E. coli (Lee et al. 1983).
Virulence characteristics
Virulence characteristics, also called virulence factors, are bacterial products that
contribute to virulence. When the virulence factors are deleted, the pathogenic potential of the
microbe is impaired. In addition to virulence factors, pathogens possess several virulence
mechanisms--strategies that promote pathogenicity and the maintenance of their niche.
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Bacterial adherence to host cells is of special importance for the persistence of bacteria
in the oral cavity, small intestine, and urinary tract, surfaces that are cleansed by body fluids.
Adherence is mediated by fimbriae, hair-like protein structures that extend from the bacterial
cell surface and bind to host cell molecules, or bacterial surface proteins that mediate tight
binding between bacteria and host cells (Soto & Hultgren 1999). The formation of a biofilm, a
tight coaggregation of bacteria adhering to each other and to the host surface, helps the
bacteria to colonize, to resist the host defense and antimicrobial agents, and also provides good
sites for receiving nutrients (Beveridge et al. 1997).
Bacteria have several virulence strategies to evade of the host response. Many mucosal
pathogens, such as oral streptococci, produce immunoglobulin A (IgA) proteases to cleave
secretory immunoglobulin A (SIgA), which is produced by host cells to inhibit bacterial
adherence (Marcotte & Lavoie 1998). Capsule formation may protect bacteria from the host’s
inflammatory response and from phagocytosis. Encapsulated Haemophilus influenzae strains,
especially those with a type b capsule, cause life-threatening and sometimes fatal infections,
whereas nonencapsulated (nontypeable) H. influenzae strains rarely do so (Gilsdorf 1998).
Bacteria can avoid the host response by antigenic variation: altering the surface proteins which
serve as targets for host’s antibodies (Brunham et al. 1993).
Virulence factors that damage the host tissues are exotoxins, endotoxins, and hydrolytic
enzymes. Exotoxins may have general cytotoxic effects, or they may be targeted at a certain
host cell type as are neurotoxins, leukotoxins, or hepatotoxins (Salyers & Whitt 1994).
Virulence due to exotoxin release is typical for Corynebacterium diphtheriae, Vibrio cholerae,
and Clostridium tetani (Salyers & Whitt 1994, Casadevall & Pirofski 1999). Endotoxin refers
to lipopolysaccharide (LPS), a component of the outer membrane of gram-negative bacteria
(Proctor et al. 1995). Instead of being directly toxic to host cells, LPS provokes the host
response by stimulating the host cells to produce endogenous substances, such as cytokines
(Proctor et al. 1995, Helander et al. 1996).
The host response may be activated, in addition to toxins, also by autoimmune
modulators of bacteria. This response is observed in rheumatic fever when streptococcal M
proteins of Streptococcus pyogenes cross-react with heart tissue cells (Salyers & Whitt 1994).
Heat shock protein (HSP) production is a defense mechanism against various environmental
stresses for both eukaryotic and prokaryotic cells (Ellis 1996), but it may also play an
important role in the virulence of microbial pathogens (Lathigra et al. 1991). Bacterial HSPs
are proteins conserved during evolution and they show a high homology between different
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bacterial species and also with human HSP (Ando et al. 1995, Multhoff et al. 1998, Zügel &
Kaufmann 1999). Therefore, the bacterial HSPs may cross-react with the host and evoke an
autoimmune response, such as suggested in rheumatoid arthritis or insulin-dependent diabetes
mellitus (Kaufmann 1990, Zügel & Kaufmann 1999). Recently, Chlamydia pneumoniae and
human HSP60s have been found to activate human vascular cells by mechanisms that
contribute to atherogenesis (Kol et al. 1999).
Characteristics associated with virulence of A. actinomycetemcomitans
The wide range of virulence characteristics of A. actinomycetemcomitans ensures its
survival in the oral cavity and enhances its capacity to cause periodontal destruction (for
reviews see Wilson & Henderson 1995, Fives-Taylor et al. 1999). Table 1 summarizes the
various virulence characteristics of A. actinomycetemcomitans and gives a general overview of
their biological activities. In addition to their virulence characteristics, bacteria possess several
mechanisms to promote pathogenicity or interfere with host tissue repair and healing after
infection. What follows concentrates on those A. actinomycetemcomitans virulence-associated
characteristics and mechanisms that have been objects of the present studies.
Intraspecies diversity
Differences have been observed in the detection frequency and pathogenic potential of
certain A. actinomycetemcomitans strains in various periodontal conditions. A.
actinomycetemcomitans serotype b strains are associated with both LJP and adult periodontitis
(Zambon et al. 1983, Asikainen et al. 1991). Elevated pathogenic potential has been suggested
for some oral A. actinomycetemcomitans clones by their association with conversion from a
healthy state to periodontal destruction (DiRienzo et al. 1994, Bueno et al. 1998) or
association with advanced periodontitis (Asikainen et al. 1995, He et al. 1998, Macheleidt et al.
1999). On the contrary, certain A. actinomycetemcomitans serotype c strains or AP-PCR
genotypes, since they are frequently isolated from periodontally healthy subjects, may possess
decreased virulence (Asikainen et al. 1991, 1995, Macheleidt et al. 1999). Additionally,
adherence to epithelial cells (Meyer & Fives-Taylor 1994) and the capacity to invade human
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cells (Meyer et al. 1991, Lepine et al. 1998) are observed to vary between A.
actinomycetemcomitans strains.
Serotypes and nonserotypeability
The serotypes of A. actinomycetemcomitans are defined by the manner in which the
carbohydrate cell-surface antigens react with antisera against A. actinomycetemcomitans (Slots
et al. 1982, Zambon et al. 1984). Serotype-specific antigens of A. actinomycetemcomitans
comprise more than 90% of neutral sugars and a small amount of fatty acids (Amano et al.
1989, Shibuya et al. 1991) and are suggested to reside in the O antigen of LPS. Table 2
presents studies on serotype-specific antigens of A. actinomycetemcomitans.
 According to current knowledge, A. actinomycetemcomitans strains that react with
none of the antisera raised against the five serotypes (a through e) (Saarela et al. 1992, Gmür et
al. 1993) are defined as nonserotypeable. Nonserotypeable strains have been detected by an
immunodiffusion method with serotype-specific polyclonal rabbit antisera against the five
serotypes (Saarela et al. 1992), by indirect immunofluorescence with serotype-specific
monoclonal antibodies (Gmür et al. 1993), and by immunostaining with human sera containing
high antibody titers to A. actinomycetemcomitans (Gmür et al. 1993). No observations have
been made on the serotype switching of A. actinomycetemcomitans during the course of a
periodontal infection (Saarela et al. 1992, 1999). In some other bacterial species, however,
antigenic variation is common; Borrelia hermsii switches the serotype during relapsing fever
(Barbour et al. 1991) and H. influenzae alters the immunodominant epitopes during
colonization (Foxwell et al. 1998). It remains unknown whether the nonserotypeable A.
actinomycetemcomitans strains are variants of the serotypeable strains or represent a new
serotype. Additionally, the bacterial mechanisms involved in allowing an A.
actinomycetemcomitans strain to remain nonserotypeable and unrecognized by the host, are
not yet clear.
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Table 1. Virulence-associated characteristics of A. actinomycetemcomitans.






Mediation of bacterial cell adherence and attachment to
epithelial cells, to other bacteria, and to extracellular
matrix proteins
Meyer & Fives-Taylor 1994
Bacteriocin (actinobacillicin) Inhibition of the growth or killing of other bacterial
species, e.g., Streptococcus sanguis and Actinomyces
viscosus, and other A. actinomycetemcomitans strains
Hammond et al. 1987
Invasins Aid in bacteria penetrating eukaryotic cells Sreenivasan et al. 1993
Iron-repressible protein, iron-regulated
protein
Enhancement of iron utilization from the environment or
the host
Winston et al. 1993, Willemsen
et al. 1997
Immunoinhibitory characteristics
Chemotaxis inhibitor Disruption and inhibition of PMN chemotaxis Van Dyke et al. 1982
Production of Fc-binding proteins Inhibition of complement activation, downregulation of
B-cell response
Tolo & Helgeland 1991, Mintz
& Fives-Taylor 1994
Resistance to killing and phagocytosis Inhibition of PNMs’ ability to produce antibacterial
compounds, or intrinsic resistance to antibacterial
compounds
Ashkenazi et al. 1992
Production of Ig proteases Degradation of IgG, serum IgA, and IgM Gregory et al. 1992
Capsular polysaccharide Resistance to phagocytosis by PMNs, reduction in
complement-dependent response by PMNs, increase
in bone resorption
Yamaguchi et al. 1995, 1998,
Wilson et al. 1985
A variety of surface antigens Aid in avoiding host antibodies and antibody production Ebersole et al. 1996,
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Nakashima et al. 1997
Immunosuppressive factors Inhibition of DNA, RNA, and protein synthesis in T-
lymphocytes and production of IgG and IgM in B-
lymphocytes, downregulation of cytokine production
Shenker et al. 1982, 1990,
Kurita-Ochiai & Ochiai
1996
Cytolethal distending toxins (formerly
immunosuppressive factor)
Eukaryotic cell, especially lymphocyte, distension and
death
Sugai et al. 1998, Shenker et
al. 1999, Mayer et al. 1999
Leukotoxin Killing of PMNs, monocytes, and T-lymphocytes Baehni et al. 1979, Tsai et al.
1979, Mangan et al. 1991
Toxin from culture supernatant Fibroblast growth inhibition, apoptosis in B-lymphocytes Helgeland & Nordby 1993,
Ohguchi et al. 1998
Epitheliotoxin Aid in penetrating the sulcular epithelium Birkedal-Hansen et al. 1982
Lipopolysaccharide Bone resorption, local Schwartzman reaction, and tissue
inflammation by inducing inflammatory mediator
production from host cells
Kiley & Holt 1980, Saglie et al.
1990
GroEL-like heat shock protein Bone resorption, epithelial-cell cytotoxicity and
proliferation
Kirby et al. 1995, Goulhen et
al. 1998
Surface-associated material PMN cytotoxicity, fibroblast anti-proliferativity, bone
resorption
Meghji et al. 1992, White et al.
1995
Hemolysin Lysing of human erythrocytes Kimizuka et al. 1996
Proteinase production Degradation of host proteins Robertson et al. 1982, Suido et
al. 1986, Uitto et al. 1988,
Wang et al. 1999
Phospholipase C Hydrolyzation of host cell membranes Mayrand et al. 1996
Extracellular membranous vesicles Mediation of endotoxic, leukotoxic, and bone resorption
activities
Lai et al. 1981, Nowotny et al.
1982
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Table 2. Serotype-specific antigens in A. actinomycetemcomitans.
Serotypes Antigen extraction methods Antigen characterization and comments References
a, b, c Sonication and ethanol
precipitation of cell-free
culture supernatant
Mannose-containing carbohydrate, polysaccharides on the cell
surface.
Slots et al. 1982,
Zambon et al. 1984,
1988
a, b, c Sonicated whole cells Carbohydrate, possibly capsular polysaccharide. Serotype-specific
antigens are the immunodominant antigens in periodontitis patients
with high antibody levels against A. actinomycetemcomitans of
serotypes b and c, but not of serotype a.
Califano et al. 1989,
1991, 1992
a, b, c Supernatant of autoclaved
whole cells
Polymer consisting of a disaccharide repeating unit (serotype b) and
closely related repeating units (serotypes a, and c). Serotype-
specific antigens differ from O polysaccharides of LPS.
Amano et al. 1989,
Shibuya et al. 1991
b Phenol-water extraction of
LPS from whole cells
Serotype-specific antigen is in the polysaccharide of LPS. Wilson & Schifferle
1991
b Boiled and sonicated whole
cells
Serotype-specific antigen, the immunodominant antigen in juvenile
periodontitis patients, resides in the high-molecular-mass
carbohydrate rich LPS fraction.
Sims et al. 1991, Page
et al. 1991
b Sonicated whole cells Serotype-specific antigen is a high-molecular-weight polysaccharide
separable from LPS. Antigen of capsular material.
McArthur et al. 1996
a, b, c, d, e Phenol extraction of LPS
and purification of O
polysaccharide
Polymer consisting of disaccharide (serotypes a, c, and e),
trisaccharide (serotype b), and tetrasaccharide (serotype d)
repeating units. Serotype-specific antigens are in the O
polysaccharide of LPS.




LPS consists of a lipid A portion, a core, and a polysaccharide (O antigen) (Hitchcock
et al. 1986). The highly variable carbohydrate O antigen is the immunodominant antigen in
several bacterial species and presents to the host various antigenic structures (Proctor et al.
1995, Helander et al. 1996). The lipid A portion of LPS is highly conserved, exhibiting the
smallest structural variation in LPS, with different LPS core structures existing mainly between
different genera (Helander et al. 1996).
The serotype b-specific antibody binding to A. actinomycetemcomitans is mediated
through the LPS O antigen (Page et al. 1991, Wilson & Schifferle 1991). LPS O
polysaccharide is of a unique chemical composition in each of the reference strains representing
all five A. actinomycetemcomitans serotypes (Perry et al. 1996a, 1996b), supporting the view
that in all A. actinomycetemcomitans serotypes the serotype-specific antigens are localized in
the O-antigenic polysaccharide of LPS. However, some controversy exists, with studies
suggesting that serotype determinants in A. actinomycetemcomitans are polysaccharides
structurally differing from the O antigen, or that A. actinomycetemcomitans may produce
multiple serotype-specific polysaccharides (Amano et al. 1989, Shibuya et al. 1991, McArthur
et al. 1996). Among Salmonella species, the presence or length of the O antigen defines the
virulence of the bacteria (Valtonen 1970, Helander et al. 1996). No differences, however, have
been seen in the periodontal disease state of subjects with nonserotypeable A.
actinomycetemcomitans strains compared to those with serotypeable strains (Asikainen et al.
1991, 1995, Saarela et al. 1999).
Besides acting as an antigenic structure to the host, A. actinomycetemcomitans LPS
stimulates cytokine production from PMNs, monocytes, and macrophages (Saglie et al. 1990,
Agarwal et al. 1995, Yoshimura et al. 1997). Additionally, LPS alterations have been reported
to be responsible for antimicrobial resistance in Pseudomonas aeruginosa and E. coli (Leying
et al. 1992, Tarr et al. 1998). No data are available on the effects of LPS alterations in the
antimicrobial susceptibility of A. actinomycetemcomitans strains.
Outer membrane proteins
The major outer membrane proteins (OMPs) of A. actinomycetemcomitans are largely
similar in A. actinomycetemcomitans serotypes a, b, and c (DiRienzo & Spieler 1983, Bolstad
et al. 1990, Muller et al. 1990, van Steenbergen et al. 1994). One nonserotypeable A.
actinomycetemcomitans strain has exhibited OMP patterns similar to those of serotypeable
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strains (van Steenbergen et al. 1994). However, some differences in OMP patterns have
recently been found between four A. actinomycetemcomitans strains with rough and smooth
colony morphologies (Haase et al. 1999). Growth of A. actinomycetemcomitans in 5% CO2 in
air or in anaerobiosis may affect its cell-surface ultrastructure and surface protein expression
(Scannapieco et al. 1987). Its OMPs have been identified as targets for immunoglobulin G
(IgG) antibodies in sera from LJP patients (Bolstad et al. 1990, Wilson & Hamilton 1995), and
as proteins binding to the Fc portion of immunoglobulins (Mintz & Fives-Taylor 1994).
OMP profiles show antigenic heterogeneity among subtypes of nontypeable H.
influenzae and can be used for serotyping the isolates (Murphy & Apicella 1985). The
typeability of H. influenzae, as seen by antisera reacting with the bacterial capsule (Gilsdorf
1998), however, is different from the serotypeability of A. actinomycetemcomitans, which is
seen when antisera react with carbohydrate cell-surface antigens (Slots et al. 1982, Zambon et
al. 1984). Therefore, the A. actinomycetemcomitans OMPs may not be likely candidates for
the differentiation between serotypeable and nonserotypeable strains. However, little
information is available on the OMPs of nonserotypeable A. actinomycetemcomitans strains.
Polymorphism of genes
In A. actinomycetemcomitans, genes responsible for leukotoxic (Lally et al. 1989) and
cytotoxic (Mayer et al. 1999) activities have been characterized. Genes of A.
actinomycetemcomitans encoding for proteins essential for its survival in environmental
changes, such as reduced iron availability (Winston et al. 1993) or elevated temperature
(Winston et al. 1996, Minami et al. 1998), have been cloned and sequenced. No information is
available on other stress-associated gene expression such as apaH (Farr et al. 1989) in A.
actinomycetemcomitans.
Leukotoxin
Leukotoxin is among the most studied virulence factors of A. actinomycetemcomitans.
Its leukotoxin is a member of the repeats-in-toxin (RTX) exoprotein family of pore-forming
hemolysins/leukotoxins (Welch 1995) and is specifically cytotoxic to human
polymorphonuclear leukocytes (PMNs), monocytes, and T-lymphocytes (Baehni et al. 1979,
Tsai et al. 1979, Mangan et al. 1991). It has recently been shown to induce apoptosis in
promyelocytic cell line HL-60 (Korostoff et al. 1998). A high production of leukotoxin is
associated with A. actinomycetemcomitans strains isolated from patients with LJP (Zambon et
24
al. 1996, Bueno et al. 1998). All A. actinomycetemcomitans strains seem to have genes that
code for leukotoxin (Poulsen et al. 1994); a deletion in the leukotoxin gene promoter region
leads to expression of increased leukotoxic activity (Brogan et al. 1994). This deletion of the
leukotoxin gene promoter structure of oral A. actinomycetemcomitans is rare (Brogan et al.
1994) and has not been detected in strains from northern Europe (Haubek et al. 1995,
Asikainen et al. 1997). Little information exists as to the leukotoxin gene promoter structure of
A. actinomycetemcomitans strains from nonoral infections.
Heat shock proteins
HSPs are produced as a protection against stress (Ellis 1996), but they also play a role
under normal conditions during the cell cycle, development, and differentiation (Bukau &
Horwich 1998). HSPs may additionally function as molecular chaperones ensuring that protein
assembly into higher order structures occurs correctly (Ellis 1996).
Several authors have reported in A. actinomycetemcomitans the presence of HSPs,
including GroEL-like (HSP60) and DnaK-like (HSP70) proteins (Koga et al. 1993,
Løkensgaard et al. 1994, Nakano et al. 1995, Hinode et al. 1998, Goulhen et al. 1998). Protein
homologous to GroEL-like HSP found in the surface-associated material of A.
actinomycetemcomitans has osteolytic activity by murine bone resorption assay (Kirby et al.
1995). Purified native GroEL-like HSP from A. actinomycetemcomitans promotes epithelial-
cell proliferation at lower HSP concentrations, but has a toxic effect on epithelial cells at higher
HSP concentrations (Goulhen et al. 1998). There are to the best of our knowledge, no
previous studies comparing HSP expression between several clinical strains of any bacterial
species, and, thus no information is available on the relation of HSP expression to the course of
an infection.
As mentioned above, bacterial and human HSPs share high sequence homology.
Antibodies raised against GroEL-like proteins from A. actinomycetemcomitans, P. gingivalis,
and B. forsythus show a high level of cross-reactivity to each other (Hinode et al. 1998), and
may also react with HSP65 from H. influenzae and E. coli (Nakano et al. 1995). Autoimmune
mechanisms may play a role in gingivitis and periodontitis. Salivary IgA antibodies against
mycobacterial HSP65 are significantly increased in patients with gingivitis (Schett et al. 1997),
and the proliferative response of peripheral blood mononuclear cells from periodontitis patients
to HSPs is lowered (Petit et al. 1999).
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Antimicrobial resistance
Antimicrobial resistance of a pathogen may be associated with its virulence.
Antimicrobial resistance may promote the persistence of a pathogen in the infected host during
antimicrobial treatment and lead to prolonged or life-threatening infections. Resistance may
also contribute to the quick and unlimited spread of a pathogen in a population. Approximately
30% of oral A. actinomycetemcomitans are resistant to benzylpenicillin (Slots et al. 1980b,
Walker et al. 1985), the most commonly used antimicrobial agent in treatment of oral
infections. In severe nonoral A. actinomycetemcomitans infections the antimicrobial
susceptibility of the pathogen plays a crucial role in the recovery of the patient. The data on
antimicrobial susceptibility of nonoral A. actinomycetemcomitans strains are restricted to
separate case reports from laboratories around the world.
Production of betalactamase enzyme is the major penicillin resistance mechanism,
especially among gram-negative bacteria (Hedberg & Nord 1996), but it has not been observed
in A. actinomycetemcomitans strains (Slots et al. 1980b). New or altered penicillin-binding
proteins on the bacterial cell-surface may account for the non-enzymatic penicillin resistance of
A. actinomycetemcomitans, as has been observed among strains of H. influenzae (Clairoux et
al. 1992). Poor permeability of the outer membrane may be responsible for the antimicrobial
resistance in gram-negative organisms. Additionally, an active efflux mechanism may transport
the drug from the cytoplasm out of the bacterial cell, as observed in E. coli and P. aeruginosa
(Nikaido 1998).
Stimulation of the epithelial response
In periodontal destruction, bacterial substances mainly interact with mononuclear
phagocytic cells and fibroblasts (Page & Schroeder 1977, World Workshop in Periodontics
1996). However, cells of junctional epithelium and periodontal pocket epithelium are the first
host cells to face the bacteria during the microbial challenge in periodontitis (Schroeder 1996).
Bacteria and bacterial products in the periodontal pocket evoke the host defense and stimulate
epithelial cells to produce enzymes such as matrix metalloproteinases (Birkedal-Hansen et al.
1993, Uitto et al. 1998), cytokines such as interleukins and tumor necrosis factor-α (Kornman
et al. 1997, Okada & Murakami 1998), or antimicrobial peptides such as β-defensins
(Weinberg et al. 1998). The epithelial-cell response to A. actinomycetemcomitans includes
stimulation of chymotrypsin-like enzyme secretion (Firth et al. 1996), increased secretion of
26
interleukin-8 and intercellular adhesion molecule-1 (Huang et al. 1998), and activity promoting
epithelial-cell proliferation or death (Meghji et al. 1992, Goulhen et al. 1998).
Cell proliferation, when occurring in the apical direction in the junctional epithelium, is
a key mechanism in the formation and deepening of the periodontal pocket. The development
of a model for junctional epithelium (Pan et al. 1995) by culturing periodontal ligament
epithelial cells, isolated from epithelial cell rests of Malassez (Brunette et al. 1976), has made
possible in vitro studies on junctional epithelium. A. actinomycetemcomitans HSP60 increases
epithelial-cell proliferation and therefore may promote the progression of periodontal disease
(Goulhen et al. 1998). On the other hand, inhibition of this epithelial-cell proliferation by A.
actinomycetemcomitans (Meghji et al. 1992, Goulhen et al. 1998) may delay healing and repair
of host tissues after periodontal infection. Information on the proliferative effects of clinical A.
actinomycetemcomitans strains on epithelial cells is limited, and it is not known whether heat-
stressed clinical strains provoke responses similar to those of purified HSP.
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AIMS OF THE STUDY
The hypothesis of the studies included in this thesis was that differences exist in the
virulence characteristics among A. actinomycetemcomitans strains. Nonserotypeable A.
actinomycetemcomitans strains and A. actinomycetemcomitans strains from nonoral infections
were assumed to demonstrate higher virulence than that of serotypeable A.
actinomycetemcomitans strains or strains originating in the periodontally healthy oral cavity.
The general aim of the present study was to find A. actinomycetemcomitans strains
with elevated virulence properties by determining why some A. actinomycetemcomitans strains
remain nonserotypeable, by characterizing A. actinomycetemcomitans strains from nonoral
infections, and by studying the heat-induced stress response of A. actinomycetemcomitans
strains in relation to the in vitro effects on epithelial-cell viability.
The specific questions were:
1. Do nonserotypeable and serotypeable A. actinomycetemcomitans strains have a common
origin? (I)
2. In comparison with serotypeable strains, do nonserotypeable A. actinomycetemcomitans
strains have cell-surface alterations that contribute to their antigenicity? (II)
3. Do certain characteristics of A. actinomycetemcomitans strains from nonoral infections
differ from those of strains from the oral cavity? (III)
4. Does heat shock protein expression contribute to the variable ability of clinical A.
actinomycetemcomitans strains to induce epithelial-cell proliferation or death? (IV)
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MATERIAL AND METHODS
Subjects and bacterial strains
A total of 170 A. actinomycetemcomitans strains and 6 reference strains of other
bacterial species were used in the present studies (Table 3).
Table 3. Number of bacterial strains used in Studies I, II, III, and IV.
Bacterial strains I II III IV
Test strains
Actinobacillus actinomycetemcomitans
Oral, serotypeable 18* 12 - 3
Oral, nonserotypeable 75 12 - 1
Nonoral, serotypeable - - 50 2
Nonoral, nonserotypeable - - 2 -
Control strains1
A. actinomycetemcomitans
Oral, serotypeable - 3 20 -
Oral, nonserotypeable - - 1 -
Reference strains2
A. actinomycetemcomitans 3 3 1 6
Haemophilus influenzae - 2 2 -
H. aphrophilus - 2 2 -
Staphylococcus aureus - 1 1 -
E. coli - 1 1 -
Total 96 36 80 12
1 Control strains are human isolates from the collection of the Institute of Dentistry, University
of Helsinki.
2 Reference strains are from international (ATCC, NCTC) strain collections in addition to
acknowledged A. actinomycetemcomitans reference strains from the Institute of Dentistry,
University of Helsinki (IDH) and a kind gift from Professor J. Slots (JP2).
Studies on the nonserotypeability of A. actinomycetemcomitans (I, II)
The study material comprised 75 nonserotypeable oral A. actinomycetemcomitans
isolates from 34 unrelated subjects (age-range 14-68 years). These isolates came from our
strain collection of more than 1,300 A. actinomycetemcomitans strains at the Institute of
Dentistry, University of Helsinki, and comprised all nonserotypeable A.
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actinomycetemcomitans strains available. Each of the 34 subjects contributed 1 to 12 (mean
2.7) A. actinomycetemcomitans isolates, of which 1 to 7 (mean 2.2) were serologically
nontypeable. Of the 34 subjects, 6 (age-range 31-57 years) harbored both serotypeable (n =
18) and nonserotypeable (n = 12) isolates--each contributed 2 to 6 isolates--and these isolates
were used to compare the serotypeable and nonserotypeable isolates from the same subjects.
All of the isolates originated in samples of subgingival plaque and saliva, and samples from the
tongue surface or oral mucosa. Three A. actinomycetemcomitans ATCC strains (ATCC
29523, ATCC 43718, and ATCC 33384) were included in the material as reference strains,
and three clinical strains from LJP or adult periodontitis were included as control strains. In
addition, Haemophilus influenzae ATCC 49247 and ATCC 49766, H. aphrophilus ATCC
13252 and NCTC 5906, Staphylococcus aureus ATCC 25923, and E. coli ATCC 25922 were
included as reference strains in the antimicrobial susceptibility testing.
Studies on nonoral A. actinomycetemcomitans (III)
The bacterial collection comprised 52 A. actinomycetemcomitans strains from 51
subjects (ages unknown) with various nonoral infections and 21 oral strains from 21 subjects
(age-range 14-71 years) with periodontitis or with healthy periodontium. The A.
actinomycetemcomitans strains from nonoral infections were obtained from geographically
distant locations. One source was the Culture Collection at the University of Gothenburg in
Sweden (Sweden, n = 24; Austria, n = 1; Germany, n = 2; and the United States, n = 1),
another source was international research groups with published or unpublished data on
nonoral A. actinomycetemcomitans infections (Iceland, n = 4; Belgium, n = 2; New Zealand, n
= 6; and Taiwan, n = 4), and a third source was patients with unpublished A.
actinomycetemcomitans infections from hospitals in Finland (n = 8).
The 21 oral A. actinomycetemcomitans strains were selected from our culture
collection to match the serotype and genotype distributions of those nonoral strains, and they
originated in subjects with periodontitis, gingivitis, or healthy periodontium. A.
actinomycetemcomitans strain JP2 was used as a positive control strain in the analysis of
leukotoxin gene promoter structure. H. influenzae ATCC 49247 and ATCC 49766, H.
aphrophilus ATCC 13252 and NCTC 5906, S. aureus ATCC 25923, and E. coli ATCC 25922
were included as reference strains in the antimicrobial susceptibility testing.
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Studies on the heat shock response of A. actinomycetemcomitans and its effects on
epithelial-cell proliferation and cytotoxicity (IV)
The study bacteria comprised 12 A. actinomycetemcomitans strains from 11 subjects.
The clinical strains were selected from the previous studies (I, II, III) to represent various oral
and nonoral infections, and the healthy oral cavity. Reference strains (ATCC 29523, ATCC
43718, ATCC 33384, IDH 781, IDH 1705, and JP2), representing all five A.
actinomycetemcomitans serotypes, were also included.
Methods
Culture and identification (I, II, III, IV)
A. actinomycetemcomitans strains were grown on Trypticase soy-serum-bacitracin-
vancomycin agar plates (Slots 1982b) and incubated in 5% CO2 in air at 37°C for 2 to 3 days.
Isolates were identified as A. actinomycetemcomitans if they presented a typical colony
morphology, a positive catalase reaction, and a negative result for lactose fermentation
(Asikainen et al. 1986, Saarela et al. 1992). Subcultures started from a single colony were
preserved in 20% skim milk at -70°C until used.
Serotyping (I, III)
Antigens for serotyping were prepared from A. actinomycetemcomitans cells grown in
5 ml of Todd-Hewitt broth (Difco Laboratories, Detroit, MI) in 5% CO2 in air at 37°C for 2 to
3 days. Bacterial cells were collected by centrifugation, washed once with distilled water,
suspended in 150 µl of 0.9% NaCl, and autoclaved at 120°C for 15 min. Undiluted serotype-
specific rabbit antisera made against whole cells of A. actinomycetemcomitans serotypes a to e
(Saarela et al. 1992) were used in an immunodiffusion assay carried out in 1.2% Noble agar
(Difco) (Saarela et al. 1992). A. actinomycetemcomitans strains representing the five serotypes
were ATCC 29523 (serotype a), ATCC 43718 (serotype b), ATCC 33384 (serotype c), IDH
781 (serotype d), and IDH 1705 (serotype e).
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Polymerase chain reaction (PCR) assays (I, III)
DNA extraction for PCR amplifications. Chromosomal DNA used as a template in
PCR amplifications was extracted from A. actinomycetemcomitans strains by a modification of
the method of Moncla and coworkers (1990). Briefly, after lysozyme incubation and 10% SDS
and proteinase K digestions, proteins were removed by extractions with phenol:chloroform and
chloroform. DNA was precipitated by using sodium acetate, dried under vacuum, and
dissolved in Tris-EDTA buffer (Saarela et al. 1995).
Arbitrarily primed PCR (AP-PCR) genotyping. The random sequence
oligonucleotide OPA-13 (5'-CAGCACCCAC-3') (Operon Technologies, Inc., Alameda, CA)
was used as a primer for all A. actinomycetemcomitans isolates (Slots et al. 1993, Asikainen et
al. 1995). Two additional primers, OPA-03 (5'-AGTCAGCCAC-3') and OPA-07 (5'-
GAAACGGGTG-3'), were used for selected isolates indistinguishable by OPA-13 primer
(Slots et al. 1993). AP-PCR was performed as previously described (Asikainen et al. 1995).
Amplification products were analyzed electrophoretically in 1% (wt/vol) agarose gel
containing ethidium bromide (0.5 mg/ml) and visualized under ultraviolet light.
apaH PCR amplification and restriction analysis. Primers used in the PCR
amplification of the apaH gene were 5’-ATTTAATCGGCGACCTGCAC-3’ and 5’-
TGTCTTCCCAACGTAGCATG-3’ (Saarela et al. 1998). PCR amplification was performed
as previously described (Saarela et al. 1998). Amplification products were characterized by
restriction analysis by use of restriction endonucleases SphI and NheI as previously described
(Saarela et al. 1998).
Analysis of leukotoxin promoter structure by PCR. The primer pair 5’-ATA TTA
AAT CTC CTT GT-3’ and 5’-ACC TGA TAA CAG TAT T-3’ (Brogan et al. 1994) was used
to amplify a DNA fragment from the leukotoxin promoter region of A.
actinomycetemcomitans strains. PCR amplification was performed as described earlier
(Asikainen et al. 1997). A positive control, DNA of highly leukotoxic A.
actinomycetemcomitans strain JP2 (an amplicon of 470-bp) (Brogan et al. 1994) and a
negative control (reaction mixture without template) were included in each PCR amplification.
Amplification products were analyzed electrophoretically in 1% (wt/vol) agarose gel
containing ethidium bromide (0.5 mg/ml) and visualized under ultraviolet light.
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Antimicrobial susceptibility testing (II, III)
The minimum inhibitory concentrations (MICs) of six antimicrobial agents for A.
actinomycetemcomitans strains were determined by the agar dilution method with
Haemophilus test medium according to established methods and to the instructions of the
National Committee for Clinical Laboratory Standards (NCCLS) (1998a, 1998b). The six
antimicrobial agents included benzylpenicillin, amoxicillin, tetracycline, metronidazole,
azithromycin, and trovafloxacin.
Preparation of A. actinomycetemcomitans cell-surface structures (II)
Isolation of A. actinomycetemcomitans outer membrane proteins (OMPs). Outer
membrane proteins of the bacterial strains were prepared by the modified methods of Filip et
al. (1973) and of Chen and Wilson (1990). A. actinomycetemcomitans strains were grown on
Trypticase soy agar (Difco) plates in 5% CO2 in air at 37°C for 2 to 3 days. Bacterial colonies
were suspended in phosphate-buffered saline (PBS, pH 7.4) and disrupted with a sonicator
(Sonifier Branson 250) using a 50% duty cycle at output 6 for 4.5 min. Intact cells and
insoluble debris were removed by centrifugation at 3,000 × g for 10 min. The total membrane
fraction in the supernatant was recovered by centrifugation at 100,000 × g for 1 h, and treated
with 1% Sarkosyl (sodium-lauroyl sarcosinate, Sigma Chemical Co., St. Louis, MO) for 1 to 4
h at room temperature. The Sarkosyl solution was centrifuged at 100,000 × g for 1 h to collect
the sarkosyl-insoluble outer membrane fraction, and the pellet comprising the outer membrane
complex (OMC) was suspended in distilled water.
Isolation of A. actinomycetemcomitans lipopolysaccharide (LPS). The LPS fraction
was prepared from OMC (Chen & Wilson 1990): part of the OMC fraction was dispersed in
lysing buffer (5% 2-mercaptoethanol, 2% SDS, 10% glycerol, and 0.125 M Tris-Cl, pH 6.8)
and solubilized by incubation at 100°C for 10 min. The material was cooled to room
temperature, 10 µl of proteinase K (10 mg/ml) was added, and the solution was incubated at
60°C for 60 min.
Heat shock and fractionation of A. actinomycetemcomitans cells (IV)
The bacteria were first grown on Trypticase soy agar (Difco) and then in Todd-Hewitt
broth (Difco) supplemented with 1% yeast extract at 35°C in anaerobic jars filled with mixed
gas (85% N2, 10% H2, 5% CO2). For each A. actinomycetemcomitans strain, two agar plates
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for the recovery of whole cells and two broth cultures (100 ml) for the fractionation of
bacterial cells were either grown at 35°C (control, non-shocked) or at 43°C (heat-shocked) for
2 h. Whole bacterial cells were then collected from the agar plates and placed in tubes
containing 1 ml of PBS.
The fractionation of A. actinomycetemcomitans cells was performed according to a
modification of the method of Goulhen and coworkers (1998). Briefly, bacterial cells were
exposed to osmotic shock with ice-cold distilled water for 5 min, the suspension was
centrifuged, and the supernatant containing the periplasmic material was lyophilized. The cells
were disrupted by ultrasonic treatment (Sonifier Branson 250) by using a 20% duty cycle at
output 3 for 5 min and centrifuged at 6,000 × g for 15 min. The supernatant was then
centrifuged at 200,000 × g for 2 h. The resulting supernatant was dialyzed against distilled
water and contained the cytoplasmic material. The pellet was resuspended in distilled water
and contained the cell membrane fraction (cytoplasmic and outer membranes).
Analysis of OMPs, LPS, and heat shock proteins of A. actinomycetemcomitans (II, IV)
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). SDS-
PAGE was performed according to the modified Laemmli gel system (Laemmli 1970) on a
vertical gel apparatus Mini-Protean II (Bio-Rad Laboratories, Richmond, CA). OMP
electrophoresis was carried out with 12.5% resolving gels run at 200 V, and protein bands
were visualized by staining with Coomassie brilliant blue R-250 (CBB) (Serva, Heidelberg,
Germany). The LPS electrophoretic patterns were assessed with 15% resolving gels run at 200
V and visualized by silver staining (Hitchcock & Brown 1983). LPS from E. coli 0111:B4
(Sigma), Salmonella serotype Typhimurium SH 2183 (smooth) (Valtonen 1970), Salmonella
serotype Typhimurium SH 5014 (Rb2) (Nurminen et al. 1976), A. actinomycetemcomitans Y4
(serotype b), and A. actinomycetemcomitans IDH 781 (serotype d) were used as references.
The protein concentration in the HSP samples was determined by a dye-binding assay
(Bio-Rad kit) with BSA as a standard. HSP electrophoresis was carried out with 10%
resolving gels run at 200 V for 45 min and proteins were stained with CBB. In all SDS-PAGE
assays 4% stacking gels were used.
Western immunoblotting. A. actinomycetemcomitans LPSs were transferred onto a
nitrocellulose membrane by a NovaBlot Electrophoretic Transfer kit with Multiphor II
(Pharmacia LKB Biotechnology, Uppsala, Sweden). Western immunoblotting was performed
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according to a modification of the method of Towbin's group (1979). The primary antibody
was either rabbit antiserum against the one serotype which was detected from the
serotypeable/nonserotypeable pair of A. actinomycetemcomitans strains from each study
subject, or alternatively, a pool of rabbit antisera against serotypes a, b, and c (1:5,000
dilution). Both were incubated for 1 h. Serotype-specific rabbit antisera had been made against
whole cells of A. actinomycetemcomitans serotypes a to e (Saarela et al. 1992). The
membranes were then incubated with the secondary antibody: goat anti-rabbit IgG conjugated
to horseradish peroxidase (1:1,000 dilution, Sigma) for 1 h. Peroxidase staining (Sigma) was
carried out to visualize the results of the immunoblotting.
A. actinomycetemcomitans cell fractions for the HSP immunodetection were
transferred onto a nitrocellulose membrane by Mini Trans-Blot Electrophoretic Transfer Cell
(Bio-Rad). Western immunoblotting was performed by incubating the membrane with the
primary antibodies, rabbit antiserum against native GroEL-like protein (1:1,000 dilution) from
a heat-shocked A. actinomycetemcomitans strain ATCC 29522 (serotype b) (Hinode et al.
1996) and a commercial antibody against HSP70 protein (1:3,000 dilution, Dako Corporation,
Carpinteria, CA) for 2 h as described previously (Hinode et al. 1996). The membrane was
further incubated with the secondary antibody goat anti-rabbit IgG conjugated to alkaline
phosphatase (1:3,000 dilution, Bio-Rad) for 1 h. The reactions were visualized by alkaline
phosphatase staining. The strength of HSP expression in the immunoblots was measured by
scanning and computer analysis (NIH Image). The computerized analysis of the GroEL
expression in the membrane fraction ranged from 0 to 3,000 relative units for weak, from
3,000 to 5,000 units for moderate, and 5,000 units or more for strong expression.
Epithelial-cell growth and viability assays (IV)
Porcine periodontal ligament epithelial cells (PLE cells), which resemble the junctional
epithelial cells in humans (Pan et al. 1995), were cultured in minimal Eagle medium containing
0.01% penicillin G (w/v), 0.1% gentamycin sulphate (v/v), 1.2% fungizone (w/v) (Gibco BRL;
30 µg amphotericin B and 24.6 µg sodium deoxycholate per ml final concentration), and 10%
fetal bovine serum. Cells were cultured in 5% CO2 at 37°C for 2 to 4 days depending on the
assay; to 50% confluence for proliferation assays and to 100% confluence for cytotoxicity
assays. PLE cells were cultured for a further 24 to 48 h in the presence of A.
actinomycetemcomitans whole-cell or membrane preparations (heat-shocked and controls).
Proliferation assays were performed in the presence of serum to facilitate further epithelial-cell
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growth, whereas cytotoxicity assays were performed in the absence of serum to prevent the
epithelial cells from further growth. The number of viable PLE cells was studied by
measurement of the conversion of tetrazolium salt into blue formazan with Cell Titer 96 kit
(Promega, Madison, WI). The results were of optical density at 570 nm and reflected the
amount of viable PLE cells. Cytotoxicity assays gave negative figures reflecting PLE cell loss,
which were then converted to positive figures reflecting the number of dead cells.
Statistical methods (III)
The statistical significance for the differences between frequency distributions of
nonoral A. actinomycetemcomitans serotypes, genotypes, and antimicrobial susceptibilities was
determined by Chi-square statistics and Fisher’s exact test.
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RESULTS AND DISCUSSION
Nonserotypeability of A. actinomycetemcomitans (I, II)
More than 90% of clinical A. actinomycetemcomitans strains are serotypeable. A.
actinomycetemcomitans strains that remain nonserotypeable may exhibit elevated virulence by
impeding detection by the host, since serotype-specific antigens are the immunodominant
antigens in A. actinomycetemcomitans -positive periodontitis patients (Califano et al. 1989,
1991). During the course of an infection some pathogens alter their cell-surface structures to
evade a host response (Barbour et al. 1991, Foxwell et al. 1998). Cell-surface alterations may
contribute to the nonserotypeability of A. actinomycetemcomitans. If no cell-surface alterations
are found, a new serotype may be present. Therefore, 75 nonserotypeable A.
actinomycetemcomitans strains, all the nonserotypeable strains available, were characterized in
Studies I and II.
Characterization of nonserotypeable A. actinomycetemcomitans strains
Nonserotypeable oral A. actinomycetemcomitans strains were characterized by use of
AP-PCR genotyping and apaH restriction analysis. AP-PCR technique, a rapid method in the
clonal analysis of A. actinomycetemcomitans (Slots et al. 1993), distinguished, among the 75
nonserotypeable strains originating in 34 subjects, eight AP-PCR genotypes (Fig. 1 from
original publication I). Six of these eight AP-PCR genotypes were similar to those found in the
previous studies (Asikainen et al. 1995, 1996, 1997) and thus corresponded to previously
known serotypes or nonserotypeable isolates. Two AP-PCR genotypes within two subjects had
not been detected previously.
The most common AP-PCR genotype among the nonserotypeable A.
actinomycetemcomitans strains was genotype 3, as categorized by Asikainen et al. (1995),
which corresponds to serotype c (Asikainen et al. 1995). The results obtained with the apaH
restriction analysis showed the same trend as the previous findings (Saarela et al. 1998): strains
with a serotype c-like restriction pattern predominate among nonserotypeable A.
actinomycetemcomitans strains. When the nonserotypeable A. actinomycetemcomitans strains
were grouped into AP-PCR genotypes, according to Asikainen et al. (1995, 1996), and
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corresponding to different serotypes, the distribution was: "serotype a" in 6 subjects (18%),
"serotype b" in 3 subjects (9%), "serotype c" in 21 subjects (62%) and "serotype d" in 1
subject (3%) (Table 1 from original publication I). Twelve A. actinomycetemcomitans strains
from three subjects remained "nonserotypeable" with AP-PCR. The present results obtained by
AP-PCR genotyping of nonserotypeable A. actinomycetemcomitans strains show a discrepancy
with the previous reports on the serotype distribution of oral A. actinomycetemcomitans.
Among A. actinomycetemcomitans strains isolated from 91 (Saarela et al. 1992) and 356
(Dogan et al. 1999a) Finnish subjects, serotypes a, b, and c are about equally represented
(25%, 29%, and 23%-26%, respectively) and serotypes d and e are rare (3%-4% and 6%-10%,
respectively). Taken together, the previous reports and present results show that the A.
actinomycetemcomitans AP-PCR genotype corresponding to serotype c is far more common in
nonserotypeable strains than could be expected based on the general serotype distribution of
oral A. actinomycetemcomitans strains (62% versus 23%-26%). This result suggests that
nonserotypeable A. actinomycetemcomitans strains represent a population of strains that
originally were serotypeable, and that serotype c strains may lose their ability to react with
serotype-specific antiserum easier than do strains of the other serotypes. The results of Poulsen
et al. (1994) also suggest that nonserotypeable strains originate from strains of known
serotypes. Characterization of eight nonserotypeable A. actinomycetemcomitans strains
showed that these strains were distributed in different evolutionary lines of the A.
actinomycetemcomitans population, and they were genetically closely related to other strains
of their respective clusters (Poulsen et al. 1994). However, the present results do not fully
exclude the possibility that a new A. actinomycetemcomitans serotype representing the
serotype c-specific AP-PCR genotype will be found if a larger sample of nonserotypeable A.
actinomycetemcomitans strains is analyzed.
Two of the eight AP-PCR genotypes found in the present study among the
nonserotypeable A. actinomycetemcomitans strains were not known from the previous studies
(Asikainen et al. 1995, 1996, 1997). One or both of these two genotypes, plus one previously
found genotype among three nonserotypeable strains (Asikainen et al. 1995), may represent
one or more novel A. actinomycetemcomitans serotypes. The existence of new serotype(s)
needs further study.
Multiple nonserotypeable A. actinomycetemcomitans strains were isolated from 23/34
subjects participating in the study. These strains showed clonality per subject in 22/23, whereas
one subject had two AP-PCR genotypes. Therefore, the present Finnish subjects harboring
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nonserotypeable A. actinomycetemcomitans strains are most likely to have only one clone of
the organism per subject, as previously observed among serotypeable A.
actinomycetemcomitans strains from Finnish subjects (Asikainen et al. 1995, 1996) and
recently also from Japanese subjects (He et al. 1998).
Comparison of serotypeable and nonserotypeable A. actinomycetemcomitans strains
from the same subjects
Of the 34 subjects with nonserotypeable A. actinomycetemcomitans strains, six also
harbored serotypeable strains. In each subject the serotypeable and nonserotypeable A.
actinomycetemcomitans strains produced what seemed to be identical AP-PCR banding
patterns. This unique material, 12 strains of serotypes a, b, and c and 12 nonserotypeable
strains all simultaneously isolated from six subjects, inspired the testing of the material to see
whether the cell-surface structures of nonserotypeable A. actinomycetemcomitans strains
differed from those of serotypeable strains.
In Western immunoblotting with serotype-specific antisera, nonserotypeable A.
actinomycetemcomitans strains of serotype b- and c-specific AP-PCR genotypes lacked the
clear LPS profile that was present in the serotypeable strains from the same subjects (Fig. 3B
and 3C from original publication II). This LPS profile was seen as a smear in the high-
molecular-weight O-antigenic region of LPS in immunoblots of serotypeable strains only,
although the SDS-PAGE/silver staining of the gels showed no apparent differences in the LPSs
between serotypeable and nonserotypeable A. actinomycetemcomitans strains (Fig. 2 from
original publication II). These results suggest that alterations in the LPS of the present
nonserotypeable A. actinomycetemcomitans strains of serotype b- or c-specific AP-PCR
genotypes has led to lack of reactivity with the serotype-specific antisera. The LPS alteration
seems to be in the O antigen of LPS, since the serotypeable A. actinomycetemcomitans strains
give typical O-antigenic profiles in the immunoblots. Our present results support the previous
studies' findings that the serotype-specific structures of A. actinomycetemcomitans are in the
long-chain high-molecular-weight O antigen of LPS (Page et al. 1991, Wilson & Shifferle
1991, Perry et al. 1996a, 1996b). In notable contrast to the previous and present results, some
studies suggest that A. actinomycetemcomitans strains of serotypes a, b, and c produce
multiple serotype-specific polysaccharides separable from the LPS O antigen (Amano et al.
1989, Shibuya et al. 1991), or that the serotype b antigen is an A. actinomycetemcomitans
capsular material (McArthur et al. 1996). Although a crude LPS extraction method may not
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separate the serotype-specific antigen from LPS (Amano et al. 1989, Shibuya et al. 1991), our
present LPS extraction method seems to be a valid one, giving the same immunoblotting
profile as phenol-extracted LPS from A. actinomycetemcomitans strain Y4 (serotype b).
Three of the six study subjects simultaneously harbored serotype c and nonserotypeable
A. actinomycetemcomitans strains which comprised two-thirds of the 24 A.
actinomycetemcomitans strains (Study II). This suggests that serotype c strains are more prone
to alter their antigenicity, showing the same trend as the nonserotypeable A.
actinomycetemcomitans strains (Study I). Similar changes in the LPS may occur among
serotype b strains, although results for serotype b strains are based on only three strains from a
single subject. Conversely, the LPS profiles of serotype a and nonserotypeable A.
actinomycetemcomitans strains from the same subjects were similar in the immunoblots (Fig.
3A from original publication II). Reasons for the nonserotypeability of A.
actinomycetemcomitans strains of serotype a-specific AP-PCR genotypes cannot be explained
by the results with the present methods and need to be further investigated.
The serotypeable and nonserotypeable A. actinomycetemcomitans strains shared great
similarity in outer membrane protein patterns both within one subject and between subjects
(Fig. 1 from original publication II). This suggests homology of the major OMPs of A.
actinomycetemcomitans, as has been shown by earlier studies; four to five major cell envelope
proteins dominate in all serotypes studied (a, b, and c) of several A. actinomycetemcomitans
strains (DiRienzo & Spieler 1983, Muller et al. 1990, Bolstad et al. 1990, van Steenbergen et
al. 1994). Recently, however, differences in OMP patterns have been found between the rough
and smooth colony morphologies within four A. actinomycetemcomitans strains: two proteins
(43 and 20 kDa) are expressed by the rough variants exclusively (Haase et al. 1999). All of the
clinical serotypeable and nonserotypeable A. actinomycetemcomitans strains studied here were
of rough colony types and expressed these two proteins.
In some bacterial species, such as P. aeruginosa and E. coli, antimicrobial resistance
may vary due to LPS or O antigen alterations (Leying et al. 1992, Tarr et al. 1998). The slight
differences in antimicrobial susceptibility between serotypeable and nonserotypeable A.
actinomycetemcomitans strains (Table 2 from original publication II) are not likely, however,
to be due to LPS alterations. Differences in MICs were seen against only one of the six
antimicrobial agents studied, in strains from two of the six subjects, and these were no more
than two dilution steps away from each other.
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Characterization of nonoral A. actinomycetemcomitans strains (III)
The oral cavity is the ecological niche for A. actinomycetemcomitans, but the organism
is occasionally isolated from infections at other than oral sites, as well. Presently it is unknown
whether the nonoral environment favors any particular characteristics of A.
actinomycetemcomitans or whether only certain A. actinomycetemcomitans strains cause
nonoral infections. To study the possible differences between nonoral and oral A.
actinomycetemcomitans strains, we determined serotypes and genotypes, antimicrobial
susceptibilities, and leukotoxin gene promoter structures of 73 nonoral and oral A.
actinomycetemcomitans strains. A total of 52 A. actinomycetemcomitans strains from 51
subjects with various nonoral infections (Table 1 from original publication III) were collected
from distant geographic locations (See Material and Methods). Oral A.
actinomycetemcomitans strains (n = 21) from our culture collection at the Institute of
Dentistry, University of Helsinki, were obtained from 21 subjects. The oral strains matched the
serotypes and genotypes of nonoral strains and were used as a control group for the leukotoxin
gene determination and antimicrobial susceptibility testing.
Serotype, genotype, and leukotoxin determinants of nonoral A. actinomycetemcomitans
Serotype and AP-PCR genotype distributions of the nonoral A.
actinomycetemcomitans strains showed wide heterogeneity: all five known serotypes and two
nonserotypeable strains were recovered (Table 2 from original publication III). The major
serotypes were a, b, and c (16%, 41%, and 31% of subjects) and smaller proportions were of
serotypes d and e, or nonserotypeable strains (8%, 2%, and 4%). One subject harbored two A.
actinomycetemcomitans serotypes, b and c. The AP-PCR genotyping distinguished 10 different
genotypes among the nonoral strains (Fig. 1 from original publication III), showing that
nonoral A. actinomycetemcomitans infections may result from a variety of clones.
Serotype distribution of the present nonoral A. actinomycetemcomitans strains strongly
resembles that of oral A. actinomycetemcomitans strains when all five serotypes are determined
(Saarela et al. 1992, Yamamoto et al. 1997, Dogan et al. 1999a). A. actinomycetemcomitans
serotype b, which is associated with periodontal disease (Zambon et al. 1983, Asikainen et al.
1991), was predominant (41% of subjects) in nonoral infections. The absence of virulent clonal
types--characterized by a deletion in the leukotoxin gene promoter--among A.
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actinomycetemcomitans strains from nonoral infections, corroborated that of oral strains of
northern European and non-African origin, where this virulent clone has not been detected
(Haubek et al. 1995, Asikainen et al. 1997). The present results agree with the idea of the oral
cavity's being the ecological niche of A. actinomycetemcomitans and the likely origin of
nonoral A. actinomycetemcomitans strains. However, the present findings on serotype
distribution of nonoral A. actinomycetemcomitans strains differ from previous results (Zambon
et al. 1988). The data of Zambon et al. (1988) suggest that serotype c predominates in nonoral
infections: 22 (73%) of the 30 A. actinomycetemcomitans strains were of serotype c. The
number of A. actinomycetemcomitans strains included in the present study and in that of
Zambon et al. (1988) are still limited, which, together with the different serotyping methods,
may account for the differences between the present and that study.
Four of the AP-PCR genotypes comprising as many as 22 (42%) of 52 nonoral strains
had not been found in earlier studies (Asikainen et al. 1995, 1996, 1997, Study I, Dogan et al.
1999b). Since these works have mainly included oral A. actinomycetemcomitans strains from
Finnish subjects, the present finding of previously undetectable AP-PCR genotypes is likely
due to the widespread geographic origins of the present strains, but does not rule out the
possible existence of specific A. actinomycetemcomitans clones in nonoral infections.
Associations between A. actinomycetemcomitans clones and specific nonoral infections
Generally, the characteristics of nonoral A. actinomycetemcomitans strains resembled
those of the oral strains. However, some interesting correlations appeared between certain
strains and the recovery site: blood or focal infections. Serotype b was more prevalent (49%
versus 20%, Table 2 from original publication III) in blood samples from endocarditis and
bacteremia patients than in focal infections which are likely less severe than blood infections.
Additionally, A. actinomycetemcomitans AP-PCR genotype 3 occurred statistically
significantly (p=0.020) more frequently in subjects with focal infections (33%) than in the
blood samples (6%) (Table 2 from original publication III). These findings suggest that certain
A. actinomycetemcomitans clones are of importance in nonoral infections. Due to serotype- or
genotype-dependent factors, some A. actinomycetemcomitans strains may exhibit tropism for
certain tissues, such as the endocardium. Previously, from a total of 15 distinguishable A.
actinomycetemcomitans AP-PCR genotypes, this particular AP-PCR genotype 3 was the most
frequent one (32%) in the oral cavities of periodontally healthy subjects (Asikainen et al.
1995). Further studies are, however, needed to determine whether certain characteristics
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enable strains of this genotype to colonize healthy oral cavities or preferentially cause localized
nonoral infections.
Antimicrobial susceptibility patterns
The antimicrobial agent susceptibility tests revealed no differences in MICs at which
50% (MIC50) or 90% (MIC90) of strains are inhibited between the nonoral and oral A.
actinomycetemcomitans strains (Table 3 from original publication III). Amoxicillin,
tetracycline, azithromycin, and trovafloxacin showed good activity against all A.
actinomycetemcomitans strains, regardless of the recovery site. According to the NCCLS
breakpoints suggested for Haemophilus spp. susceptibility interpretation (NCCLS 1998a,
1998b, and Table 3 from original publication III), it was observed that of all 73 A.
actinomycetemcomitans strains studied, approximately 30% were resistant to benzylpenicillin
and 5% to metronidazole. All the resistant strains were of serotypes a, b, or c (Table 4 from
original publication III).
Our present results on the penicillin resistance of nonoral and oral A.
actinomycetemcomitans strains largely corroborate those of other studies on the antimicrobial
susceptibilities of oral A. actinomycetemcomitans strains (Slots et al. 1980b, Walker et al.
1985, Pajukanta et al. 1993, Avila-Campos et al. 1995, Madinier et al. 1999). A.
actinomycetemcomitans strains do not produce penicillinase (Slots et al. 1980b), and therefore
their resistance to benzylpenicillin does not seem to be beta-lactamase-mediated. Instead, it
may be related to changes in penicillin-binding proteins, as has been observed with the
penicillin resistance among strains of H. influenzae (Clairoux et al. 1992), a close phylogenetic
relative of A. actinomycetemcomitans. Additionally, the poor permeability of the gram-
negative outer membrane may account for the penicillin resistance of A.
actinomycetemcomitans. Resistance to benzylpenicillin occurred among A.
actinomycetemcomitans serotype b strains (62%), especially among two AP-PCR genotypes (2
and 12) of serotype b (Table 4 from original publication III). The same trend appeared both in
nonoral and in oral A. actinomycetemcomitans strains. The benzylpenicillin resistance of A.
actinomycetemcomitans is mainly of academic interest, since this antimicrobial agent is not the
first choice in the treatment of chronic periodontal infections. However, the penicillin
resistance of A. actinomycetemcomitans serotype b strains, suggesting specific properties such
as new or altered penicillin-binding proteins, needs further study.
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According to the NCCLS breakpoints for anaerobic bacteria (NCCLS 1998b) four
(5%) of 73 A. actinomycetemcomitans strains, two nonoral and two oral strains, were resistant
to metronidazole. Two of the resistant strains were of serotype b and two of serotype c, all
four strains being of different AP-PCR genotypes. Several studies have shown that resistance
to metronidazole occurs among oral A. actinomycetemcomitans strains (Slots et al. 1980b,
Walker et al. 1985, Jousimies-Somer et al. 1988, Pajukanta et al. 1993, Avila-Campos et al.
1995, Madinier et al. 1999), which can be expected due to its aerotolerance. Amoxicillin, the
currently recommended antimicrobial agent for use as endocarditis prophylaxis in dental
procedures (Dajani et al. 1997), showed good activity against all present A.
actinomycetemcomitans strains, and therefore can be anticipated to be effective as endocarditis
prophylaxis for periodontitis patients harboring oral A. actinomycetemcomitans. The present
results for amoxicillin corroborate other antimicrobial susceptibility studies for oral A.
actinomycetemcomitans strains (Walker et al. 1985, Madinier et al. 1999). Additionally,
trovafloxacin, a new quinolone which has not previously been tested against A.
actinomycetemcomitans, showed high activity against the study strains. Trovafloxacin shows
excellent activity against several microaerophilic bacterial species (Väisänen et al. 1997), but
presently has been taken off the market, since it recently proved to be hepatotoxic in humans.
However, the high activity of trovafloxacin shows that old quinolones, such as ciprofloxacin,
norfloxacin, and ofloxacin, and new quinolones, such as levofloxacin, most likely will show
good activity against A. actinomycetemcomitans.
Heat shock response of A. actinomycetemcomitans and its effects on
epithelial cells (IV)
Heat shock protein (HSP) expression, which has been shown to contribute to the
virulence of several organisms (Lathigra et al. 1991), may play a role in the pathogenic
potential of A. actinomycetemcomitans. HSP expression has not previously been linked to A.
actinomycetemcomitans infection. Therefore, 12 A. actinomycetemcomitans strains,
representing all known serotypes from various oral and nonoral infections, were investigated to
find differences in HSP expression among several A. actinomycetemcomitans strains. GroEL-
like and DnaK-like HSPs were localized in cell fractions of A. actinomycetemcomitans, and the
44
effects of whole A. actinomycetemcomitans cells and protein-rich cell membrane fractions on
periodontal ligament epithelial cells were studied.
Localization and expression of heat shock proteins in A. actinomycetemcomitans
GroEL- and DnaK-like proteins were detected both in heat-shocked and non-shocked
A. actinomycetemcomitans cell fractions. HSP production in the absence of stress has
previously been reported in A. actinomycetemcomitans (Goulhen et al. 1998), E. coli (Bukau
et al. 1993), and Haemophilus ducreyi (Parsons et al. 1997). This is possible when HSPs,
besides being protection against stressful conditions (Ellis 1996), are expressed in normal
conditions during the cell cycle, development, and differentiation (Bukau & Horwich 1998).
Methodological aspects may explain the minor differences observed between non-shocked and
heat-shocked strains; the presently used heat-shocking time (2 h) may have been long enough
for A. actinomycetemcomitans to induce an adaptation process instead of a mere stress
response. It is also possible that the commonly used anaerobic and microaerophilic culture
method itself is stressful for A. actinomycetemcomitans.
GroEL- and DnaK-like HSPs in the microbial cells are mainly intracellular proteins, but
the localization may vary, depending on the organism. Since the HSP localization in several
bacterial species is variable, the intracellular/cell surface localization may account for the
different pathogenic characteristics of various bacteria. In all the A. actinomycetemcomitans
strains, GroEL-like protein (HSP60) was found in the membranes, cytoplasm, and periplasm,
whereas DnaK-like protein (HSP70) was present only in the cytoplasmic and periplasmic
fractions (Fig. 1 from original publication IV). GroEL-like protein from two A.
actinomycetemcomitans laboratory strains has been shown to be located in the soluble cell
fractions and in the membrane fraction (Goulhen et al. 1998). This is similar to GroEL
localization in Helicobacter pylori (Phadnis et al. 1996). DnaK-like protein has been reported
to be localized intracellularly in A. actinomycetemcomitans (Goulhen et al. 1998), Borrelia
burgdorferi (Scorpio et al. 1994), and E. coli, in which, additionally, a subpopulation of
DnaK-like protein may become membrane-associated (Bukau et al. 1993). In some bacteria,
expression of GroEL- and DnaK-like proteins is coupled. This is the case with H. ducreyi,
where DnaK serves as a downregulating modifier of GroEL expression (Parsons et al. 1997).
The relative amounts of GroEL- and DnaK-like protein expression in the A.
actinomycetemcomitans strains could not, however, be determined in our study, because two
distinct antibodies were used in the immunoblot analysis.
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Some differences were observed in the GroEL- and DnaK-like protein expressions
among the present A. actinomycetemcomitans strains. The GroEL expression in A.
actinomycetemcomitans membrane fractions of different strains was defined as weak,
moderate, or strong (Fig. 2 from original publication IV). In Fig. 3 from original publication
IV, A. actinomycetemcomitans strains are arranged in order of increasing strength of GroEL
expression in the membrane fraction. No correlation was observed between HSP expressions
and the serotype or the origin (oral/nonoral, disease/health) of A. actinomycetemcomitans
strains. One strain (CCUG 37418) from endocarditis expressed the membrane-associated
GroEL-like protein strongly, whereas another strain (CCUG 37000R) from endocarditis
expressed it weakly. Interestingly, a strain (IDH I31A) from one healthy oral cavity expressed
GroEL-like protein more strongly than did two strains (JP2 and IDH 2765) from severe
juvenile periodontitis.
Relationship between membrane-associated GroEL expression and epithelial-cell
proliferation
The membrane fraction of A. actinomycetemcomitans is of special interest, because the
HSP localization on the bacterial cell surface enables rapid HSP expression into the
environment and makes possible the quick contact of HSP with human cells. At low
concentrations (0.1-1.0 µg protein/ml) the membrane fraction of A. actinomycetemcomitans
strains that expressed the GroEL-like protein moderately or strongly induced epithelial-cell
proliferation stronger than did strains that expressed GroEL-like protein weakly (Fig. 3 from
original publication IV). This suggests a correlation between membrane-associated expression
of A. actinomycetemcomitans GroEL-like protein and epithelial-cell proliferation. The cell
culture studies were made by using porcine periodontal ligament epithelial cells which had been
isolated from epithelial rests of Malassez (Brunette et al. 1976) and represent a model for
human junctional epithelium (Pan et al. 1995). Increased apical proliferation of epithelial cells
may lead to deepening of periodontal pockets and thus a larger area for bacteria to grow.
Therefore, GroEL-like HSP may account for the survival of A. actinomycetemcomitans in the
periodontal pocket, and, by increasing epithelial proliferation, play a role in the virulence of A.
actinomycetemcomitans. This fact supports the role of GroEL-like protein in the pathogenicity
of clinical A. actinomycetemcomitans strains, as has been suggested earlier by Goulhen et al.
(1998) and Kirby et al. (1995) on A. actinomycetemcomitans laboratory strains.
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HSPs may play a role in the pathogenic potential of several microbial species.
Salmonella serotype Typhimurium HSP66 is involved with the mucus-mediated interaction of
this bacterium with its host’s intestinal mucosa (Ensgraber & Loos 1992). H. pylori HSP60 is
associated with adhesion of H. pylori to human gastric epithelial cells (Yamaguchi et al. 1997),
whereas H. ducreyi has diminished ability to adhere to human cells when GroEL-like protein
expression is lowered (Parsons et al. 1997). Legionella pneumophila HSP60, found at elevated
levels early in the infection, correlates with the virulence of this organism (Fernandez et al.
1996). Among other characteristics, differences in HSP expression between the present A.
actinomycetemcomitans strains may contribute to variable host responses evoked by several
clinical A. actinomycetemcomitans strains. At higher concentration (10 µg protein/ml), all the
A. actinomycetemcomitans membrane fractions tested were cytotoxic to epithelial cells,
suggesting that the number of A. actinomycetemcomitans cells in the periodontal pocket
determines the effect--proliferation or death--on host cells. The relation of HSP expression to
the course of an infection has not been completely established with any bacterial species; no
previous studies are known to compare HSP expression between several strains from different
clinical statuses. The present results suggest that GroEL-like HSP expression of A.
actinomycetemcomitans plays a role in periodontal destruction, but further studies with mutant
strains lacking GroEL-like HSP are needed to establish this relationship.
Effects of A. actinomycetemcomitans whole cells on epithelial cells
The effects of 12 A. actinomycetemcomitans strains on epithelial-cell proliferation or
death were investigated by use of porcine periodontal ligament epithelial cell cultures in order
to discover any differences in pathogenic potential between clinical A. actinomycetemcomitans
strains. Various amounts of bacterial cell suspensions of optical density at 600 nm (OD600) =
0.5 were added to epithelial cell cultures. Thirty µl of bacterial cell suspensions comprising
10% of total volume of the culture medium was selected to be the concentration in the
subsequent experiments. At this concentration, both increase in proliferation (Figure 1) and
cytotoxic effects (Figure 2) were observed in the epithelial cells. Effects were variable between
A. actinomycetemcomitans strains, with no apparent specificity to the serotype or origin of the
strain. Proliferation and death of epithelial cells occur during the conversion of junctional
epithelium to pocket epithelium, and both are important mechanisms in the formation of a
periodontal pocket. Cell proliferation and death are functionally opposite effects, but they can
be induced by the same effector molecules in a single cell type. For instance, increase in cell
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proliferation and cell death have both been observed with interferon-γ in human malignant T-
cells (Novelli et al. 1994), interleukin-1β in thymoma cells (Fratelli et al. 1995),
Mycobacterium tuberculosis HSP10 in teratocarcinoma cells (Galli et al. 1996), and purified
A. actinomycetemcomitans GroEL-like protein in epithelial cells (Goulhen et al. 1998).
The present results regarding effects on epithelial-cell proliferation and death cannot be
directly compared between whole cells and cell fractions in the same A.
actinomycetemcomitans strain because of the distinctive growing media used, agar plates for
whole cells and broth for cell fractions. Although the growth atmosphere was anaerobic in both
cases, the liquid medium may favor other characteristics of A. actinomycetemcomitans than on
solid medium. The presently noted proliferative and cytotoxic effects of both non-shocked and
heat-shocked A. actinomycetemcomitans strains on epithelial cells may not be explainable by
expression of HSPs only, but are likely also due to other A. actinomycetemcomitans virulence
factors, such as specific cytotoxins (Baehni et al. 1979, Tsai et al. 1979, Shenker et al. 1982,
1999), LPS (Kiley & Holt 1980), cell surface-associated materials (Meghji et al. 1992), or
proteinase production (Suido et al. 1986, Uitto et al. 1988, Wang et al. 1999). However, based
on epithelial cell culture studies with cell fractions of A. actinomycetemcomitans strains,
GroEL-like heat shock protein appears to be one of the virulence determinants of A.
actinomycetemcomitans.
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Figure 1. PLE cells were grown in the presence of whole A. actinomycetemcomitans cells and
10% serum. The number of viable PLE cells was measured with Cell Titer 96 Kit (Promega).
Values are optical density at 570 nm (mean of 3 samples) reflecting number of viable cells.
Mean value of cultures without added bacteria has been subtracted.
Figure 2. PLE cells were grown in the presence of whole A. actinomycetemcomitans cells in
the absense of serum. Number of viable PLE cells was measured with Cell Titer 96 Kit
(Promega). Values are optical density at 570 nm (mean of 3 samples). Results gave negative
figures of viable PLE cells, showing a smaller amount of cells than the mean value of cell
cultures without added bacteria. Negative figures reflecting PLE cell loss converted to positive
figures reflecting number of dead cells.
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The present studies investigated intraspecies differences in virulence-associated
characteristics between A. actinomycetemcomitans strains originating from the oral cavity and
nonoral infections. The focus was on a few specific characteristics such as nonserotypeability,
nonoral origin, and the heat shock response.
Nonserotypeable oral A. actinomycetemcomitans strains were genotypically compared
with serotypeable strains to study if they have a common origin. The nonserotypeable strains
produced a heterogenic group of AP-PCR genotypes. Most of these AP-PCR genotypes were
similar to those produced by serotypeable strains, and thus corresponded to a known serotype.
This suggests that nonserotypeable strains originate from serotypeable ones. A total of 62% of
all nonserotypeable strains produced an AP-PCR banding pattern corresponding to serotype c.
This is a markedly higher portion than could have been expected based on the general serotype
distribution among oral A. actinomycetemcomitans strains. The results suggest that the
serotype c strains lose their ability to react with the serotype-specific antiserum more easily
than do strains of the other serotypes. However, a small possibility of finding a new serotype
among nonserotypeable A. actinomycetemcomitans strains still exists.
Outer membrane proteins (OMP) and lipopolysaccharide (LPS) profiles were compared
between nonserotypeable and serotypeable oral A. actinomycetemcomitans strains from the
same subject to find reasons for the altered antigenicity of nonserotypeable strains. The OMP
patterns between serotypeable and nonserotypeable strains in each subject were similar.
Differences in the LPS profiles were observed only in Western immunoblotting;
nonserotypeable strains of serotype b- and c-specific AP-PCR genotypes lacked a clear LPS
profile, a smear in the high-molecular-weight O-antigenic region of LPS clearly present in the
serotypeable strains from the same subjects. These results suggest that altered antigenicity of
the strains, especially of serotype b- and c-specific genotypes, is due to changes in the O-
antigenic region of LPS.
Nonoral strains were compared with oral strains to see if certain characteristics of A.
actinomycetemcomitans are more often found among strains from nonoral infections. Nonoral
strains were serotypically and genotypically characterized, leukotoxin gene promoter structures
were analyzed, and antimicrobial susceptibilities were studied. Generally, these characteristics
were very similar between the nonoral strains and a control group of oral strains. Serotype b, in
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particular, predominated in nonoral infections. Serotype b was most frequently found from
bacteremia or endocarditis samples, and a certain AP-PCR genotype correlated with focal
infections. These results support the importance of certain clones in nonoral A.
actinomycetemcomitans infections. That four previously unknown AP-PCR genotypes were
found may have been due to the non-Finnish origin of the strains. Additionally, elevated
resistance was observed of both oral and nonoral A. actinomycetemcomitans serotype b strains
to benzylpenicillin.
The heat shock protein (HSP) production in A. actinomycetemcomitans strains and its
contribution to the ability to induce epithelial-cell proliferation or death were studied to seek
differences between 12 strains of various clinical origins. In all strains studied, GroEL-like
protein (HSP60) was located intracellularly and on the cell surface, whereas DnaK-like protein
(HSP70) was found only intracellularly. HSP expression varied between strains, but did not
correlate with the serotype or the origin of these strains. All strains, both heat-shocked and
non-shocked, had proliferation-promoting or cytotoxic effects on periodontal ligament
epithelial cells. The strength of GroEL-like protein expression in the membrane fraction of A.
actinomycetemcomitans correlated positively with epithelial-cell proliferation; strains that
expressed the GroEL-like protein moderately or strongly induced epithelial-cell proliferation
more strongly than did strains that expressed the protein weakly. This suggests that GroEL-
like protein plays a role in the virulence of A. actinomycetemcomitans by increasing epithelial
proliferation.
Taken together, the present studies on certain virulence-associated characteristics of A.
actinomycetemcomitans extend knowledge of the pathogen in several ways. The studies
provide information on the genetic heterogeneity of serologically nontypeable strains and
present possible reasons for A. actinomycetemcomitans nonserotypeability. The studies
additionally characterize this oral pathogen in nonoral infections and show a positive
correlation between A. actinomycetemcomitans heat shock protein expression and epithelial-
cell proliferation.
Based on the present studies, the main conclusions are that:
- Nonserotypeable oral A. actinomycetemcomitans strains originate from serotypeable ones,
especially from serotype c, and the possibility of finding additional serotypes of the species is
small.
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- A. actinomycetemcomitans serotype c strains lose their ability to react with the serotype-
specific antiserum more easily than do strains of the other serotypes.
- The altered antigenicity and nonserotypeability of certain A. actinomycetemcomitans strains,
especially strains of serotype b- and c-specific genotypes, seems to be due to changes in the O-
antigenic region of LPS.
- The serotype and genotype characterization, leukotoxin gene determinants, and antimicrobial
susceptibility patterns of nonoral A. actinomycetemcomitans strains greatly resemble those of
oral strains and thus suggest that the origin of nonoral A. actinomycetemcomitans is the oral
cavity.
- The predominance of serotype b strains in nonoral A. actinomycetemcomitans infections, and
relationships between certain serotypes or genotypes and specific infections support the
importance of certain A. actinomycetemcomitans clones in nonoral infections.
- Oral and nonoral A. actinomycetemcomitans serotype b strains are resistant to
benzylpenicillin more ofter than are strains of the other serotypes.
- Heat-shocked as well as non-shocked A. actinomycetemcomitans strains of all known
serotypes may exert both cytotoxic and hyperproliferative effects on epithelial cells.
- A positive correlation exists between membrane-associated expression of A.
actinomycetemcomitans GroEL-like heat shock protein and epithelial-cell proliferation.
- GroEL-like heat shock protein may play a role in the virulence of A. actinomycetemcomitans
by increasing epithelial-cell proliferation.
52
REFERENCES
Agarwal S, Piesco NP, Johns LP, Riccelli AE. Differential expression of IL-1β, TNF-α, IL-6, and IL-8
in human monocytes in response to lipopolysaccharides from different microbes. J Dent Res
1995;74:1057-1065.
Alaluusua S, Saarela M, Jousimies-Somer H, Asikainen S. Ribotyping shows intrafamilial similarity in
Actinobacillus actinomycetemcomitans isolates. Oral Microbiol Immunol 1993;8:225-229.
Amano K, Nishihara T, Shibuya N, Noguchi T, Koga T. Immunochemical and structural
characterization of a serotype-specific polysaccharide antigen from Actinobacillus
actinomycetemcomitans Y4 (serotype b). Infect Immun 1989;57:2942-2946.
Ando T, Kato T, Ishihara K, Ogiuchi H, Okuda K. Heat shock proteins in the human periodontal
disease process. Microbiol Immunol 1995;39:321-327.
Ashkenazi M, White RR, Dennison DK. Neutrophil modulation by Actinobacillus
actinomycetemcomitans. II. Phagocytosis and development of respiratory burst. J Periodontal Res
1992;27:457-465.
Asikainen S, Alaluusua S, Kari K, Kleemola-Kujala E. Subgingival microflora and periodontal
conditions in healthy teenagers. J Periodontol 1986;57:505-509.
Asikainen S, Lai C-H, Alaluusua S, Slots J. Distribution of Actinobacillus actinomycetemcomitans
serotypes in periodontal health and disease. Oral Microbiol Immunol 1991;6:115-118.
Asikainen S, Chen C, Slots J. Actinobacillus actinomycetemcomitans genotypes in relation to serotypes
and periodontal status. Oral Microbiol Immunol 1995;10:65-68.
Asikainen S, Chen C, Slots J. Likelihood of transmitting Actinobacillus actinomycetemcomitans and
Porphyromonas gingivalis in families with periodontitis. Oral Microbiol Immunol 1996;11:387-394.
Asikainen S, Chen C, Saarela M, Saxén L, and Slots J. Clonal specificity of Actinobacillus
actinomycetemcomitans in destructive periodontal disease. Clin Infect Dis 1997;25(Suppl 2):S227-
S229.
Avila-Campos MJ, Carvalho MAR, Zelante F. Distribution of biotypes and antimicrobial susceptibility
of Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 1995;10:382-384.
Baehni P, Tsai C-C, McArthur WP, Hammond BF, Taichman NS. Interaction of inflammatory cells
and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived gram-negative
microorganism. Infect Immun 1979;24:233-243.
Barbour AG, Burman N, Carter CJ, Kitten T, Bergstrom S. Variable antigen genes of the relapsing
fever agent Borrelia hermsii are activated by promoter addition. Mol Microbiol 1991;5:489-493.
Bayliss R, Clarke C, Oakley CM, Somerville W, Whitfield AG, Young SE. The microbiology and
pathogenesis of infective endocarditis. Br Heart J 1983;50:513-519.
Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular
disease. J Periodontol 1996;67:1123-1137.
53
Beveridge TJ, Makin SA, Kadurugamuwa JL, Li Z. Interactions between biofilms and the environment.
FEMS Microbiol Rev 1997;20:291-303.
Birkedal-Hansen H, Caufield PW, Wannemuehler YM, Pierce R. A sensitive screening assay for
epitheliotoxins produced by oral micro-organisms. J Dent Res 1982;61(Special issue):192.
Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler
JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
Bolstad AI, Kristoffersen T, Olsen I, Preus HR, Jensen HB, Vasstrand EN, Bakken V. Outer
membrane proteins of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus studied
by SDS-PAGE and immunoblotting. Oral Microbiol Immunol 1990;5:155-161.
Braconier JH, Söderström C. Indirect immunofluorescence as a diagnostic tool in a prosthetic heart
valve endocarditis due to Actinobacillus actinomycetemcomitans and Staphylococcus epidermidis.
Scand J Infect Dis 1990;22:739-741.
Brogan JM, Lally ET, Poulsen K, Kilian M, Demuth DR. Regulation of Actinobacillus
actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and
minimally leukotoxic strains. Infect Immun 1994;62:501-508.
Brunette DM, Melcher AH, Moe HK. Culture and origin of epithelium-like and fibroblast-like cells
from porcine periodontal ligament explants and cell suspensions. Archs Oral Biol 1976;21:393-400.
Brunham RC, Plummer FA, Stephens RS. Bacterial antigenic variation, host immune response, and
pathogen-host coevolution. Infect Immun 1993;61:2273-2276.
Bueno LC, Mayer MPA, DiRienzo JM. Relationship between conversion of localized juvenile
periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans
leukotoxin promoter structure. J Periodontol 1998;69:998-1007.
Bukau B, Reilly P, McCarty J, Walker GC. Immunogold localization of the DnaK heat shock protein in
Escherichia coli cells. J Gen Microbiol 1993;139:95-99.
Bukau B, Horwich AL. The hsp70 and hsp60 chaperone machines. Cell 1998;92:351-366.
Califano JV, Schenkein HA, Tew JG. Immunodominant antigen of Actinobacillus
actinomycetemcomitans Y4 in high-responder patients. Infect Immun 1989;57:1582-1589.
Califano JV, Schenkein HA, Tew JG. Immunodominant antigens of Actinobacillus
actinomycetemcomitans serotypes a and c in high-responder patients. Oral Microbiol Immunol
1991;6:228-235.
Califano JV, Schenkein HA, Tew JG. Immunodominant antigens of Actinobacillus
actinomycetemcomitans serotype b in early-onset periodontitis patients. Oral Microbiol Immunol
1992;7:65-70.
Casadevall A, Pirofski L-A. Host-pathogen interactions: redefining the basic consepts of virulence and
pathogenicity. Infect Immun 1999;67:3703-3713.
54
Chen CC-K, Wilson ME. Outer membrane protein and lipopolysaccharide heterogeneity among
Eikenella corrodens isolates. J Infect Dis 1990;162:664-671.
Chen Y-C, Chang S-C, Luh K-T, Hsieh W-C. Actinobacillus actinomycetemcomitans endocarditis: a
report of four cases and review of the literature. Q J Med 1991;81:871-878.
Clairoux N, Picard M, Brochu A, Rousseau N, Gourde P, Beauchamp D, Parr TR Jr, Bergeron MG,
Malouin F. Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in
strains of Haemophilus influenzae isolated in Canada. Antimicrob Agents Chemother 1992;36:1504-
1513.
Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri
S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr. Prevention of
bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997;96:358-
366.
Das M, Badley AD, Cockerill FR, Steckelberg JM, Wilson WR. Infective endocarditis caused by
HACEK microorganisms. Annu Rev Med 1997;48:25-33.
DiRienzo JM, Spieler EL. Identification and characterization of the major cell envelope proteins of oral
strains of Actinobacillus actinomycetemcomitans. Infect Immun 1983;39:253-261.
DiRienzo JM, Cornell S, Kazoroski L, Slots J. Probe-specific DNA fingerprinting applied to the
epidemiology of localized juvenile periodontitis. Oral Microbiol Immunol 1990;5:49-56.
DiRienzo JM, Slots J, Sixou M, Sol M-A, Harmon R, McKay TL. Specific genetic variants of
Actinobacillus actinomycetemcomitans correlate with disease and health in a regional population of
families with localized juvenile periodontitis. Infect Immun 1994;62:3058-3065.
Dogan B, Saarela MH, Jousimies-Somer H, Alaluusua S, Asikainen S. Actinobacillus
actinomycetemcomitans serotype e - biotypes, genetic diversity and distribution in relation to
periodontal status. Oral Microbiol Immunol 1999a;14:98-103.
Dogan B, Saarela M, Asikainen S. Genotyping of Actinobacillus actinomycetemcomitans serotype d
isolates based on polymerase chain reaction. Oral Microbiol Immunol 1999b;14:387-390.
Ebersole JL, Taubman MA, Smith DJ, Genco RJ, Frey DE. Human immune responses to oral micro-
organisms. I. Association of localized juvenile periodontitis (LJP) with serum antibody responses to
Actinobacillus actinomycetemcomitans. Clin Exp Immunol 1982;47:43-52.
Ebersole JL, Hall EE, Steffen MJ. Antigenic diversity in the periodontopathogen, Actinobacillus
actinomycetemcomitans. Immunol Invest 1996;25:203-214.
el Khizzi N, Kasab SA, Osoba AO. HACEK group endocarditis at the Riyadh Armed Forces Hospital.
J Infect 1997;34:69-74.
Ellis RJ. Stress proteins as molecular chaperones. In: van Eden W, Young DB, eds. Stress proteins in
medicine. New York: Marcel Dekker Inc., 1996, pp.1-26.
Ensgraber M, Loos M. A 66-kilodalton heat shock protein of Salmonella typhimurium is responsible
for binding of the bacterium to intestinal mucus. Infect Immun 1992;60:3072-3078.
55
Falkow S. Perspectives series: host/pathogen interactions. Invasion and intracellular sorting of bacteria:
searching for bacterial genes expressed during host/pathogen interactions. J Clin Invest 1997;100:239-
243.
Farr SB, Arnosti DN, Chamberlin MJ, Ames BN. An apaH mutation causes AppppA to accumulate
and affects motility and catabolite repression in Escherichia coli. Proc Natl Acad Sci USA
1989;86:5010-5014.
Fernandez RC, Logan SM, Lee SHS, Hoffman PS. Elevated levels of Legionella pneumophila stress
protein Hsp60 early in infection of human monocytes and L929 cells correlate with virulence. Infect
Immun 1996;64:1968-1976.
Filip C, Fletcher G, Wulff JL, Earhart CF. Solubilization of the cytoplasmic membrane of Escherichia
coli by the ionic detergent sodium-lauryl sarcosinate. J Bacteriol 1973;115:717-722.
Firth JD, Sue ES, Putnins EE, Oda D, Uitto V-J. Chymotrypsin-like enzyme secretion is stimulated in
cultured epithelial cells during proliferation and in response to Actinobacillus actinomycetemcomitans.
J Periodontal Res 1996;31:345-354.
Fives-Taylor PM, Hutchins Meyer D, Mintz KP, Brissette C. Virulence factors of Actinobacillus
actinomycetemcomitans. Periodontol 2000 1999;20:136-167.
Foxwell AR, Kyd JM, Cripps AW. Nontypeable Haemophilus influenzae: pathogenesis and prevention.
Microbiol Mol Biol Rev 1998;62:294-308.
Fratelli M, Gagliardini V, Galli G, Gnocchi P, Ghiara P, Ghezzi P. Autocrine interleukin-1β regulates
both proliferation and apoptosis in EL4-6.1 thymoma cells. Blood 1995;85:3532-3537.
Galli G, Ghezzi P, Mascagni P, Marcucci F, Fratelli M. Mycobacterium tuberculosis heat shock
protein 10 increases both proliferation and death in mouse P19 teratocarcinoma cells. In Vitro Cell Dev
Biol 1996;32:446-450.
Gilsdorf JR. Antigenic diversity and gene polymorphisms in Haemophilus influenzae. Infect Immun
1998;66:5053-5059.
Gmür R, McNabb H, van Steenbergen TJM, Baehni P, Mombelli A, van Winkelhoff AJ, Guggenheim
B. Seroclassification of hitherto nontypeable Actinobacillus actinomycetemcomitans strains: evidence
for a new serotype e. Oral Microbiol Immunol 1993;8:116-120.
Goulhen F, Hafezi A, Uitto V-J, Hinode D, Nakamura R, Grenier D, Mayrand D. Subcellular
localization and cytotoxic activity of the GroEL-like protein isolated from Actinobacillus
actinomycetemcomitans. Infect Immun 1998;66:5307-5313.
Gregory RL, Kim DE, Kindle JC, Hobbs LC, Lloyd DR. Immunoglobulin-degrading enzymes in
localized juvenile periodontitis. J Periodontal Res 1992;27:176-183.
Guiney DG. Perspectives series: host/pathogen interactions. Regulation of bacterial virulence gene
expression by the host environment. J Clin Invest 1997;99:565-569.
Haase EM, Zmuda JL, Scannapieco FA. Identification and molecular analysis of rough-colony-specific
outer membrane proteins of Actinobacillus actinomycetemcomitans. Infect Immun 1999;67:2901-2908.
56
Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases.
Periodontol 2000 1994;5:78-111.
Hale TL. Genetic basis of virulence in Shigella species. Microbiol Rev 1991;55:206-224.
Hammond BF, Stevens RH. Capnocytophaga and Actinobacillus actinomycetemcomitans: occurrence
and pathogenic potential in juvenile periodontitis. In: Genco RJ, Mergenhagen SE, eds. Host-parasite
interactions in periodontal diseases. Washington, D.C.: American Society for Microbiology, 1982, pp.
46-61.
Hammond BF, Lillard SE, Stevens RH. A bacteriocin of Actinobacillus actinomycetemcomitans. Infect
Immun 1987;55:686-691.
Haubek D, Poulsen K, Asikainen S, Kilian M. Evidence for absence in northern Europe of especially
virulent clonal types of Actinobacillus actinomycetemcomitans. J Clin Microbiol 1995;33:395-401.
He T, Hayashi J, Yamamoto M, Ishikawa I. Genotypic characterization of Actinobacillus
actinomycetemcomitans isolated from periodontitis patients by arbitrarily primed polymerase chain
reaction. J Periodontol 1998;69:69-75.
Hedberg M, Nord CE. Antimicrobial-resistant anaerobic bacteria in human infections. Med Microbiol
Lett 1996;5:295-304.
Helander I, Mäkelä PH, Westphal O, Rietschel ET. Lipopolysaccharides. In: Meyers RA, ed. The
Encyclopedia of Molecular Biology and Molecular Medicine. Weinheim, New York, Cambridge, Basel:
VCH Publishers, Inc., 1996, pp.462-471.
Helgeland K, Nordby Ø. Cell cycle-specific growth inhibitory effect on human gingival fibroblasts of a
toxin isolated from the culture medium of Actinobacillus actinomycetemcomitans. J Periodont Res
1993;28:161-165.
Hinode D, Grenier D, Mayrand D. A general procedure for the isolation of heat-shock proteins from
periodontopathogenic bacteria. J Microbiol Methods 1996;25:349-355.
Hinode D, Nakamura R, Grenier D, Mayrand D. Cross-reactivity of specific antibodies directed to heat
shock proteins from periodontopathogenic bacteria and of human origin. Oral Microbiol Immunol
1998;13:55-58.
Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella lipopolysaccharide
chemotypes in silver-stained polyacrylamide gels. J Bacteriol 1983;154:269-277.
Hitchcock PJ, Leive L, Mäkelä PH, Rietschel ET, Strittmatter W, Morrison DC. Lipopolysaccharide
nomenclature - past, present, and future. J Bacteriol 1986;166:699-705.
Horowitz EA, Pugsley MP, Turbes PG, Clark RB. Pericarditis caused by Actinobacillus
actinomycetemcomitans. J Infect Dis 1987;155:152-153.
Huang GT-J, Kinder Haake S, Park N-H. Gingival epithelial cells increase interleukin-8 secretion in
response to Actinobacillus actinomycetemcomitans challenge. J Periodontol 1998;69:1105-1110.
Inouye T, Ohta H, Kokeguchi S, Fukui K, Kato K. Colonial variation and fimbriation of Actinobacillus
actinomycetemcomitans. FEMS Microbiol Lett 1990;69:13-18.
57
Irving JT, Newman MG, Socransky SS, Heely JD. Histological changes in experimental periodontal
disease in rats mono-infected with a gram-negative organism. Arch Oral Biol 1975;20:219-220.
Jousimies-Somer H, Asikainen S, Suomala P, Summanen P. Activity of metronidazole and its hydroxy
metabolite against clinical isolates of Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol
1988;3:32-34.
Kagnoff MF, Eckmann L. Perspectives series: host/pathogen interactions. Epithelial cells as sensors for
microbial infection. J Clin Invest 1997;100:6-10.
Kaplan AH, Weber DJ, Odone EZ, Perfect JR. Infection due to Actinobacillus
actinomycetemcomitans: 15 cases and review. Rev Infect Dis 1989;11:46-63.
Kaufmann SHE. Heat shock proteins and the immune response. Immunol Today 1990;11:129-136.
Kiley P, Holt SC. Characterization of the lipopolysaccharide from Actinobacillus
actinomycetemcomitans Y4 and N27. Infect Immun 1980;30:862-873.
Kimizuka R, Miura T, Okuda K. Characterization of Actinobacillus actinomycetemcomitans
hemolysin. Microbiol Immunol 1996;40:717-723.
Kirby AC, Meghji S, Nair SP, White P, Reddi K, Nishihara T, Nakashima K, Willis AC, Sim R,
Wilson M, Henderson B. The potent bone-resorbing mediator of Actinobacillus
actinomycetemcomitans is homologous to the molecular chaperone GroEL. J Clin Invest
1995;96:1185-1194.
Klinger R. Untersuchungen über menschliche Aktinomycose. Zentralbl Bakteriol 1912;62:191-200.
Knox KW, Hunter N. The role of oral bacteria in the pathogenesis of infective endocarditis. Aust Dent
J 1991;36:286-292.
Koga T, Kusuzaki T, Asakawa H, Senpuku H, Nishihara T, Noguchi T. The 64-kilodalton GroEL-like
protein of Actinobacillus actinomycetemcomitans. J Periodontal Res 1993;28:475-477.
Kol A, Bourcier T, Lichtman AH, Libby P. Chlamydial and human heat shock protein 60s activate
human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999;103:571-577.
Könönen E, Asikainen S, Jousimies-Somer H. The early colonization of gram-negative anaerobic
bacteria in edentulous infants. Oral Microbiol Immunol 1992;7:28-31.
Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis:
assembling the players. Periodontol 2000 1997;14:33-53.
Korostoff J, Wang JF, Kieba I, Miller M, Shenker BJ, Lally ET. Actinobacillus
actinomycetemcomitans leukotoxin induces apoptosis in HL-60 cells. Infect Immun 1998;66:4474-
4483.
Kristinsson KG, Thorgeirsson G, Holbrook WP. Actinobacillus actinomycetemcomitans and
endocarditis. J Infect Dis 1988;157:599.
58
Kurita-Ochiai T, Ochiai K. Immunosuppressive factor from Actinobacillus actinomycetemcomitans
down regulates cytokine production. Infect Immun 1996;64:50-54.
Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature
1970;227:680-685.
Lai C-H, Listgarten MA, Hammond BF. Comparative ultrastructure of leukotoxic and non-leukotoxic
strains of Actinobacillus actinomycetemcomitans. J Periodontal Res 1981;16:379-389.
Lally ET, Golub EE, Kieba IR, Taichman NS, Rosenbloom J, Rosenbloom JC, Gibson CW, Demuth
DR. Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique
features and comparison to homologous toxins. J Biol Chem 1989;264:15451-15456.
Lathigra RB, Butcher PD, Garbe TR, Young DB. Heat shock proteins as virulence factors of
pathogens. Curr Top Microbiol Immunol 1991;167:125-143.
Lee PC, Bochner BR, Ames BN. AppppA, heat-shock stress, and cell oxidation. Proc Natl Acad Sci
USA 1983;80:7496-7500.
Lepine G, Caudry S, DiRienzo JM, Ellen RP. Epithelial cell invasion by Actinobacillus
actinomycetemcomitans strains from restriction fragment-length polymorphism groups associated with
juvenile periodontitis or carrier status. Oral Microbiol Immunol 1998;13:341-347.
Leying HJ, Buscher KH, Cullmann W, Then RL. Lipopolysaccharide alterations responsible for
combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa. Chemother 1992;38:82-
91.
Løkensgard I, Bakken V, Schenck K. Heat shock response in Actinobacillus actinomycetemcomitans.
FEMS Immunol Med Microbiol 1994;8:321-328.
Macheleidt A, Muller HP, Eger T, Putzker M, Zoller L. Clonal diversity of Actinobacillus
actinomycetemcomitans isolates from young adults with minimal periodontal disease. J Periodontal Res
1999;34:179-187.
Madinier IM, Fosse TB, Hitzig C, Charbit Y, Hannoun LR. Resistance profile survey of 50 periodontal
strains of Actinobacillus actinomycetemcomitans. J Periodontol 1999;70:888-892.
Male D, Roitt I. Introduction to the immune system. In: Roitt I, Brostoff J, Male D, eds. Immunology.
London, UK: Mosby, 1998, 5th ed., pp. 1-12.
Mangan DF, Taichman NS, Lally ET, Wahl SM. Lethal effects of Actinobacillus
actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun 1991;59:3267-3272.
Marcotte H, Lavoie MC. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol
Mol Biol Rev 1998;62:71-109.
Mattila KJ, Valtonen VV, Nieminen M, Huttunen JK. Dental infection and the risk of new coronary
events: prospective study of patients with documented coronary artery disease. Clin Infect Dis
1995;20:588-592.
Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for
atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998;26:719-734.
59
Mayer MP, Bueno LC, Hansen EJ, DiRienzo JM. Identification of a cytolethal distending toxin gene
locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect
Immun 1999;67:1227-1237.
Mayrand D, Bourassa N, Grenier D. Phospholipase C activity in selected oral bacterial species. J Dent
Res 1996;75(Special issue):130.
McArthur WP, Stroup S, McClellan S, Leung K-P. Differentiation of the serotype b and species-
specific antigens of Actinobacillus actinomycetemcomitans recognized by monoclonal antibodies. Oral
Microbiol Immunol 1996;11:209-219.
Meghji S, Wilson M, Henderson B, Kinane D. Anti-proliferative and cytotoxic activity of surface-
associated material from periodontopathogenic bacteria. Archs Oral Biol 1992;37:637-644.
Meyer DH, Sreenivasan PK, Fives-Taylor PM. Evidence for invasion of a human oral cell line by
Actinobacillus actinomycetemcomitans. Infect Immun 1991;59:2719-2726.
Meyer DH, Fives-Taylor PM. Characteristics of adherence of Actinobacillus actinomycetemcomitans
to epithelial cells. Infect Immun 1994;62:928-935.
Minami J, Matsumoto S, Yamada T. Putative heat shock protein 70 gene from Actinobacillus
actinomycetemcomitans: molecular cloning and sequence analysis of its gene. Oral Microbiol Immunol
1998;13:113-119.
Mintz KP, Fives-Taylor PM. Identification of an immunoglobulin Fc receptor of Actinobacillus
actinomycetemcomitans. Infect Immun 1994;62:4500-4505.
Molina F, Echaniz A, Duran MT, Diz-Lois F. Infectious arthritis of the knee due to Actinobacillus
actinomycetemcomitans. Eur J Clin Microbiol Infect Dis 1994;13:687-689.
Moncla BJ, Braham P, Dix K, Watanabe S, Schwartz D. Use of synthetic oligonucleotide DNA probes
for the identification of Bacteroides gingivalis. J Clin Microbiol 1990;28:324-327.
Moore WEC, Moore LVH. The bacteria of periodontal diseases. Periodontol 2000 1994;5:66-77.
Morello JA. Microbial agents in endocarditis. Clin Microbiol Newsl 1980;2:1-3.
Morris JF, Sewell DL. Necrotizing pneumonia caused by mixed infection with Actinobacillus
actinomycetemcomitans and Actinomyces israelii: case report and review. Clin Infect Dis
1994;18:450-452.
Muller D, Poolman JT, Bernadina WE, van Kol PJ, Ruitenberg EJ. Characterization of outer
membrane proteins from Actinobacillus actinomycetemcomitans. Microb Pathog 1990;9:227-233.
Multhoff G, Botzler C, Issels R. The role of heat shock proteins in the stimulation of an immune
response. Biol Chem 1998;379:295-300.
Murphy TF, Apicella MA. Antigenic heterogeneity of outer membrane proteins of nontypable
Haemophilus influenzae is a basis for a serotyping system. Infect Immun 1985;50:15-21.
60
Nakano Y, Inai Y, Yamashita Y, Nagaoka S, Kusuzaki-Nagira T, Nishihara T, Okahashi N, Koga T.
Molecular and immunological characterization of a 64-kDa protein of Actinobacillus
actinomycetemcomitans. Oral Microbiol Immunol 1995;10:151-159.
Nakashima K, Schenkein HA, Califano JV, Tew JG. Heterogeneity of antibodies reactive with the
dominant antigen of Actinobacillus actinomycetemcomitans. Infect Immun 1997;65:3794-3798.
National Committee for Clinical Laboratory Standards. Approved standard M7-A4. Methods for
dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for
Clinical Laboratory Standards 1998a, Villanova, PA.
National Committee for Clinical Laboratory Standards. Approved standard M11-A4. Methods for
antimicrobial susceptibility testing of anaerobic bacteria. National Committee for Clinical Laboratory
Standards 1998b, Villanova, PA.
Nikaido H. Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin Infect Dis
1998;27(Suppl 1):S32-S41.
Nishimura A, Moriya S, Ukai H, Nagai K, Wachi M, Yamada Y. Diadenosine 5',5'''-P1,P4-
tetraphosphate (Ap4A) controls the timing of cell division in Escherichia coli. Genes Cells 1997;2:401-
413.
Novelli F, Di Pierro F, Francia di Celle P, Bertini S, Affaticati P, Garotta G, Forni G. Environmental
signals influencing expression of the IFN-γ receptor on human T cells control whether IFN-γ promotes
proliferation or apoptosis. J Immunol 1994;152:496-504.
Nowotny A, Behling UH, Hammond B, Lai C-H, Listgarten M, Pham PH, Sanavi F. Release of toxic
microvesicles by Actinobacillus actinomycetemcomitans. Infect Immun 1982;37:151-154.
Nurminen M, Lounatmaa K, Sarvas M, Mäkelä PH, Nakae T. Bacteriophage resistant mutants of
Salmonella typhimurium deficient in two major outer membrane proteins. J Bacteriol 1976;127:941-
966.
Ohguchi M, Ishisaki A, Okahashi N, Koide M, Koseki T, Yamato K, Noguchi T, Nishihara T.
Actinobacillus actinomycetemcomitans toxin induces both cell cycle arrest in the G2/M phase and
apoptosis. Infect Immun 1998;66:5980-5987.
Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med
1998;9:248-266.
Page RC, Schroeder HE. Pathogenesis of chronic inflammatory periodontal disease: a summary of
current work. Lab Invest 1976;33:235-249.
Page RC, Schroeder HE. Structure and pathogenesis. In: Schluger S, Yuodelis RA, Page RC, eds.
Periodontal disease. Philadelphia, USA: Lea & Febiger, 1977, 1st ed., pp. 168-195.
Page RC, Sims TJ, Engel LD, Moncla BJ, Bainbridge B, Stray J, Darveau RP. The immunodominant
outer membrane antigen of Actinobacillus actinomycetemcomitans is located in the serotype-specific
high-molecular-mass carbohydrate moiety of lipopolysaccharide. Infect Immun 1991;59:3451-3462.
Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol 2000
1997;14:9-11.
61
Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of
periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000
1997;14:216-248.
Pajukanta R, Asikainen S, Saarela M, Alaluusua S, Jousimies-Somer H. In vitro antimicrobial
susceptibility of different serotypes of Actinobacillus actinomycetemcomitans. Scand J Dent Res
1993;101:299-303.
Pan YM, Firth JD, Salonen J, Uitto V-J. Multilayer culture of periodontal ligament epithelial cells: a
model for junctional epithelium. J Periodontal Res 1995;30:97-107.
Parsons LM, Limberger RJ, Shayegani M. Alterations in levels of DnaK and GroEL result in
diminished survival and adherence of stressed Haemophilus ducreyi. Infect Immun 1997;65:2413-
2419.
Perry MB, MacLean LL, Gmür R, Wilson ME. Characterization of the O-polysaccharide structure of
lipopolysaccharide from Actinobacillus actinomycetemcomitans serotype b. Infect Immun
1996a;64:1215-1219.
Perry MB, MacLean LM, Brisson J-R, Wilson ME. Structures of the antigenic O-polysaccharides of
lipopolysaccharides produced by Actinobacillus actinomycetemcomitans serotypes a, c, d and e. Eur J
Biochem 1996b;242:682-688.
Petit MD, Wassenaar A, van der Velden U, van Eden W, Loos BG. Depressed responsiveness of
peripheral blood mononuclear cells to heat-shock proteins in periodontitis patients. J Dent Res
1999;78:1393-1400.
Phadnis SH, Parlow MH, Levy M, Ilver D, Caulkins CM, Connors JB, Dunn BE. Surface localization
of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect
Immun 1996;64:905-912.
Pierce CS, Bartholomew WR, Amsterdam D, Neter E, Zambon JJ. Endocarditis due to Actinobacillus
actinomycetemcomitans serotype c and patient immune response. J Infect Dis 1984;149:479.
Poulsen K, Theilade E, Lally ET, Demuth DR, Kilian M. Population structure of Actinobacillus
actinomycetemcomitans: a framework for studies of disease-associated properties. Microbiology
1994;140:2049-2060.
Proctor RA, Denlinger LC, Bertics PJ. Lipopolysaccharide and bacterial viruelence. In: Roth JA, Bolin
CA, Brogden KA, Minion FC, Wannemuehler MJ, eds. Virulence mechanisms of bacterial pathogens.
Washington, D.C.: ASM Press, American Society for Microbiology, 1995, 2nd ed., pp. 173-194.
Robertson PB, Lantz M, Marucha PT, Kornman KS, Trummel CL, Holt SC. Collagenolytic activity
associated with Bacteroides species and Actinobacillus actinomycetemcomitans. J Periodontal Res
1982;17:275-283.
Rosan B, Slots J, Lamont RJ, Listgarten MA, Nelson GM. Actinobacillus actinomycetemcomitans
fimbriae. Oral Microbiol Immunol 1988;3:58-63.
62
Saarela M, Asikainen S, Alaluusua S, Pyhälä L, Lai C-H, Jousimies-Somer H. Frequency and stability
of mono- or poly-infection by Actinobacillus actinomycetemcomitans serotypes a, b, c, d or e. Oral
Microbiol Immunol 1992;7:277-279.
Saarela M, Asikainen S, Chen C, Alaluusua S, Slots J. Comparison of arbitrarily primed polymerase
chain reaction and ribotyping for subtyping Actinobacillus actinomycetemcomitans. Anaerobe
1995;1:97-102.
Saarela M, Asikainen S, Alaluusua S, Fives-Taylor P. apaH polymorphism in clinical Actinobacillus
actinomycetemcomitans isolates. Anaerobe 1998;4:139-144.
Saarela M, Dogan B, Alaluusua S, Asikainen S. Persistence of oral colonization by the same
Actinobacillus actinomycetemcomitans strain(s). J Periodontol 1999;70:504-509.
Saglie FR, Simon K, Merrill J, Koeffler HP. Lipopolysaccharide from Actinobacillus
actinomycetemcomitans stimulates macrophages to produce interleukin-1 and tumor necrosis factor
mRNA and protein. Oral Microbiol Immunol 1990;5:256-262.
Salman RA, Bonk SJ, Salman DG, Glickman RS. Submandibular space abscess due to Actinobacillus
actinomycetemcomitans. J Oral Maxillofac Surg 1986;44:1002-1005.
Salyers AA, Whitt DD. Bacterial pathogenesis, a molecular approach. Washington, D.C.: ASM Press,
American Society for Microbiology, 1994, pp. 30-31, 42-43, 47-48, 190-212, 335.
Scannapieco FA, Millar SJ, Reynolds HS, Zambon JJ, Levine MJ. Effect of anaerobiosis on the surface
ultrastructure and surface proteins of Actinobacillus actinomycetemcomitans (Haemophilus
actinomycetemcomitans). Infect Immun 1987;55:2320-2323.
Schett G, Metzler B, Kleindienst R, Moschen I, Hattmannsdorfer R, Wolf H, Ottenhoff T, Xu Q, Wick
G. Salivary anti-hsp65 antibodies as a diagnostic marker for gingivitis and a possible link to
atherosclerosis. Int Arch Allergy Immunol 1997;114:246-250.
Schroeder HE. The junctional epithelium: origin, structure, and significance. A review. Acta Med Dent
Helv 1996;1:155-167.
Scorpio A, Johnson P, Laquerre A, Nelson DR. Subcellular localization and chaperone activities of
Borrelia burgdorferi Hsp60 and Hsp70. J Bacteriol 1994;176:6449-6456.
Shenker BJ, McArthur WP, Tsai CC. Immune suppression induced by Actinobacillus
actinomycetemcomitans. I. Effects on human peripheral blood lymphocyte responses to mitogens and
antigens. J Immunol 1982;128:148-154.
Shenker BJ, Vitale LA, Welham DA. Immune suppression induced by Actinobacillus
actinomycetemcomitans: effects on immunoglobulin production by human B cells. Infect Immun
1990;58:3856-3862.
Shenker BJ, McKay T, Datar S, Miller M, Chowhan R, Demuth D. Actinobacillus
actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending
toxins capable of causing a G2 arrest in human T cells. J Immunol 1999;162:4773-4780.
63
Shibuya N, Amano K, Azuma J, Nishihara T, Kitamura Y, Noguchi T, Koga T. 6-Deoxy-D-talan and
6-Deoxy-L-talan. Novel serotype-specific polysaccharide antigens from Actinobacillus
actinomycetemcomitans. J Biol Chem 1991;266:16318-16323.
Sims TJ, Moncla BJ, Darveau RP, Page RC. Antigens of Actinobacillus actinomycetemcomitans
recognized by patients with juvenile periodontitis and periodontally normal subjects. Infect Immun
1991;59:913-924.
Slots J, Reynolds HS, Genco RJ. Actinobacillus actinomycetemcomitans in human periodontal disease:
a cross-sectional microbiological investigation. Infect Immun 1980a;29:1013-1020.
Slots J, Evans RT, Lobbins PM, Genco RJ. In vitro antimicrobial susceptibility of Actinobacillus
actinomycetemcomitans. Antimicrob Agents Chemother 1980b;18:9-12.
Slots J. Salient biochemical characters of Actinobacillus actinomycetemcomitans. Arch Microbiol
1982a;131:60-67.
Slots J. Selective medium for isolation of Actinobacillus actinomycetemcomitans. J Clin Microbiol
1982b;15:606-609.
Slots J, Zambon JJ, Rosling RG, Reynolds HS, Christersson LA, Genco RJ. Actinobacillus
actinomycetemcomitans in human periodontal disease. Association, serology, leukotoxicity, and
treatment. J Periodontal Res 1982;17:447-448.
Slots J, Liu B, DiRienzo M, Chen C. Evaluating two methods for fingerprinting genomes of
Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 1993;8:337-343.
Socransky SS. Criteria for the infectious agents in dental caries and periodontal disease. J Clin
Periodontol 1979;6:16-21.
Socransky SS, Haffajee AD, Smith GLF, Dzink JL. Difficulties encountered in the search for the
etiologic agents of destructive periodontal diseases. J Clin Periodontol 1987;14:588-593.
Socransky SS, Haffajee AD. Evidence of bacterial etiology: a historical perspective. Periodontol 2000
1994;5:7-25.
Soto GE, Hultgren SJ. Bacterial adhesins: common themes and variations in architecture and assembly.
J Bacteriol 1999;181:1059-1071.
Sreenivasan PK, Meyer DH, Fives-Taylor PM. Requirements for invasion of epithelial cells by
Actinobacillus actinomycetemcomitans. Infect Immun 1993;61:1239-1245.
Sugai M, Kawamoto T, Pérès SY, Ueno Y, Komatsuzawa H, Fujiwara T, Kurihara H, Suginaka H,
Oswald E. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus
actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 1998;66:5008-5019.
Suido H, Nakamura M, Mashimo PA, Zambon JJ, Genco RJ. Arylaminopeptidase activities of oral
bacteria. J Dent Res 1986;65:1335-1340.
Tarr PI, Clausen CR, Whittam TS, Wilson RA. Antibiotic resistance and O antigen expression in
Escherichia coli. J Infect Dis 1998;177:1774-1775.
64
Tolo K, Helgeland K. Fc-binding components: a virulence factor in Actinobacillus
actinomycetemcomitans? Oral Microbiol Immunol 1991;6:373-377.
Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to
nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4355.
Tsai CC, McArthur WP, Baehni PC, Hammond BF, Taichman NS. Extraction and partial
characterization of a leukotoxin from a plaque-derived gram-negative microorganism. Infect Immun
1979;25:427-439.
Uitto VJ, Haapasalo M, Laakso T, Salo T. Degradation of basement membrane collagen by proteases
from some anaerobic oral microorganisms. Oral Microbiol Immunol 1988;3:97-102.
Uitto VJ, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, Salonen J, Lopez-Otin C,
Saarialho-Kere U, Kähäri VM. Collagenase-3 (matrix metalloproteinase-13) expression is induced in
oral mucosal epithelium during chronic inflammation. Am J Pathol 1998;152:1489-1499.
Väisänen M-L, Mättö J, Salminen K, Jousimies-Somer H. In vitro activity of trovafloxacin against
anaerobic bacteria. Rev Med Microbiol 1997;8(Suppl 1):S81-S83.
Valtonen VV. Mouse virulence of Salmonella strains: the effect of different smooth-type O side-chains.
J Gen Microbiol 1970;64:255-268.
Van Dyke TE, Bartholomew E, Genco RJ, Slots J, Levine MJ. Inhibition of neutrophil chemotaxis by
soluble bacterial products. J Periodontol 1982;53:502-508.
van Palenstein Helderman WH. Microbial etiology of periodontal disease. J Clin Periodontol
1981;8:261-280.
van Steenbergen TJM, Bosch-Tijhof C-J, van Winkelhoff AJ, Gmür R, de Graaff J. Comparison of six
typing methods for Actinobacillus actinomycetemcomitans. J Clin Microbiol 1994;32:2769-2774.
van Winkelhoff AJ, Tijhof CJ, de Graaff J. Microbiological and clinical results of metronidazole plus
amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. J Periodontol
1992;63:52-57.
van Winkelhoff AJ, Overbeek BP, Pavicic MJAMP, van den Bergh JPA, Ernst JPMG, de Graaff J.
Long-standing bacteremia caused by oral Actinobacillus actinomycetemcomitans in a patient with a
pacemaker. Clin Infect Dis 1993;16:216-218.
van Winkelhoff AJ, Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in
nonoral infections. Periodontol 2000 1999;20:122-135.
Verhaaren H, Claeys G, Verschraegen G, de Niel C, Leroy J, Clement D. Endocarditis from a dental
focus. Importance of oral hygiene in valvar heart disease. Int J Cardiol 1989;23:343-347.
Walker CB, Pappas JD, Tyler KZ, Cohen S, Gordon JM. Antibiotic susceptibilities of periodontal
bacteria. In vitro susceptibilities to eight antimicrobial agents. J Periodontol 1985;56(Suppl):S67-S74.
Wang P-L, Shirasu S, Shinohara M, Daito M, Fujii T, Kowashi Y, Ohura K. Purification and
characterization of a trypsin-like protease from the culture supernatant of Actinobacillus
actinomycetemcomitans Y4. Eur J Oral Sci 1999;107:147-153.
65
Weinberg A, Krisanaprakornkit S, Dale BA. Epithelial antimicrobial peptides: review and significance
for oral applications. Crit Rev Oral Biol Med 1998;9:399-414.
Welch RA. Phylogenetic analyses of the RTX toxin family. In: Roth JA, Bolin CA, Brogden KA,
Minion FC, Wannemuehler MJ, eds. Virulence mechanisms of bacterial pathogens. Washington, D.C.:
ASM Press, American Society for Microbiology, 1995, 2nd ed., pp. 195-206.
White PA, Wilson M, Nair SP, Kirby AC, Reddi K, Henderson B. Characterization of an
antiproliferative surface-associated protein from Actinobacillus actinomycetemcomitans which can be
neutralized by sera from a proportion of patients with localized juvenile periodontitis. Infect Immun
1995;63:2612-2618.
Willemsen PTJ, Vulto I, Boxem M, de Graaff J. Characterization of a periplasmic protein involved in
iron utilization of Actinobacillus actinomycetemcomitans. J Bacteriol 1997;179:4949-4952.
Wilson M, Kamin S, Harvey W. Bone resorbing activity of purified capsular material from
Actinobacillus actinomycetemcomitans. J Periodontal Res 1985;20:484-491.
Wilson M, Henderson B. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the
pathogenesis of inflammatory periodontal diseases. FEMS Microbiol Rev 1995;17:365-379.
Wilson ME, Schifferle RE. Evidence that the serotype b antigenic determinant of Actinobacillus
actinomycetemcomitans Y4 resides in the polysaccharide moiety of lipopolysaccharide. Infect Immun
1991;59:1544-1551.
Wilson ME, Hamilton RG. Immunoglobulin G subclass response of juvenile periodontitis subjects to
principal outer membrane proteins of Actinobacillus actinomycetemcomitans. Infect Immun
1995;63:1062-1069.
Wilson MJ, Weightman AJ, Wade WG. Applications of molecular ecology in the characterization of
uncultured microorganisms associated with human disease. Rev Med Microbiol 1997;8:91-101.
Winston JL, Chen C-K, Neiders ME, Dyer DW. Membrane protein expression by Actinobacillus
actinomycetemcomitans in response to iron availability. J Dent Res 1993;72:1366-1373.
Winston JL, Toth SI, Roe BA, Dyer DW. Cloning and characterization of the Actinobacillus
actinomycetemcomitans gene encoding a heat-shock protein 90 homologue. Gene 1996;179:199-204.
Yamaguchi H, Osaki T, Kurihara N, Taguchi H, Hanawa T, Yamamoto T, Kamiya S. Heat-shock
protein 60 homologue of Helicobacter pylori is associated with adhesion of H. pylori to human gastric
epithelial cells. J Med Microbiol 1997;46:825-831.
Yamaguchi N, Kawasaki M, Yamashita Y, Nakashima K, Koga T. Role of the capsular
polysaccharide-like serotype-specific antigen in resistance of Actinobacillus actinomycetemcomitans to
phagocytosis by human polymorphonuclear leukocytes. Infect Immun 1995;63:4589-4594.
Yamaguchi N, Tsuda H, Yamashita Y, Koga T. Binding of the capsule-like serotype-specific
polysaccharide antigen and the lipopolysaccharide from Actinobacillus actinomycetemcomitans to
human complement-derived opsonins. Oral Microbiol Immunol 1998;13:348-354.
66
Yamamoto M, Nishihara T, Koseki T, He T, Yamato K, Zhang Y-J, Nakashima K, Oda S, Ishikawa I.
Prevalence of Actinobacillus actinomycetemcomitans serotypes in Japanese patients with periodontitis.
J Periodontal Res 1997;32:676-681.
Yoshimura A, Hara Y, Kaneko T, Kato I. Secretion of IL-1β, TNF-α, IL-8 and IL-1ra by human
polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. J
Periodontal Res 1997;32:279-286.
Yuan A, Yang P-C, Lee L-N, Chang D-B, Kuo S-H, Luh K-T. Actinobacillus actinomycetemcomitans
pneumonia with chest wall involvement and rib destruction. Chest 1992;101:1450-1452.
Zambon JJ, Slots J, Genco RJ. Serology of oral Actinobacillus actinomycetemcomitans and serotype
distribution in human periodontal disease. Infect Immun 1983;41:19-27.
Zambon JJ, Slots J, Miyasaki K, Linzer R, Cohen R, Levine M, Genco RJ. Purification and
characterization of the serotype c antigen from Actinobacillus actinomycetemcomitans. Infect Immun
1984;44:22-27.
Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol
1985;12:1-20.
Zambon JJ, Umemoto T, De Nardin E, Nakazawa F, Christersson LA, Genco RJ. Actinobacillus
actinomycetemcomitans in the pathogenesis of human periodontal disease. Adv Dent Res 1988;2:269-
274.
Zambon JJ, Sunday GJ, Smutko JS. Molecular genetic analysis of Actinobacillus
actinomycetemcomitans epidemiology. J Periodontol 1990;61:75-80.
Zambon JJ, Haraszthy VI, Hariharan G, Lally ET, Demuth DR. The microbiology of early-onset
periodontitis: association of highly toxic Actinobacillus actinomycetemcomitans strains with localized
juvenile periodontitis. J Periodontol 1996;67:282-290.
Zambon JJ, Haraszthy VI, Grossi S, Genco RJ. Identification of periodontal pathogens in atheromatous
plaques. J Dent Res 1997;76(Special issue):408.
Zappa U. Histology of the periodontal lesion: implications for diagnosis. Periodontol 2000 1995;7:22-
38.
Zijlstra EE, Swart GR, Godfroy FJ, Degener JE. Pericarditis, pneumonia and brain abscess due to a
combined Actinomyces--Actinobacillus actinomycetemcomitans infection. J Infect 1992;25:83-87.
Zügel U, Kaufmann SH. Role of heat shock proteins in protection from and pathogenesis of infectious
diseases. Clin Microbiol Rev 1999;12:19-39.
Zychlinsky A, Sansonetti P. Perspectives series: host/pathogen interactions. Apoptosis in bacterial
pathogenesis. J Clin Invest 1997;100:493-496.
American Academy of Periodontology. The etiology and pathogenesis of periodontal diseases.
Research, science and therapy committee. Chicago, IL: The American Academy of Periodontology,
1992, pp. 1-9.
67
World Workshop in Periodontics 1996. Periodontal diseases: pathogenesis and microbial factors.
Consensus report. Ann Periodontol 1996;1:926-932.
68
ACKNOWLEDGMENTS
This study was carried out at the Department of Periodontology, Institute of Dentistry,
University of Helsinki, during the years 1996-1999. In addition, parts of this study have been
carried out at the Anaerobe Reference Laboratory, National Public Health Institute, Helsinki;
at the Department of Oral Biological and Medical Sciences, University of British Columbia,
Vancouver, Canada; and at the Groupe de Recherche en Écologie Buccale, Université Laval,
Québec, Canada.
My warmest thanks go to my supervisor Docent Sirkka Asikainen, DDS, PhD, for
showing me the way into the wonderful world of science. I express my deepest gratitude to
her for guiding and encouraging me during this study. With her vast knowledge, enthusiasm,
and manner of scientific thinking, she has given me an admirable role-model as a researcher.
I extend my warm and sincere thanks to my second supervisor Professor Veli-Jukka
Uitto, DDS, PhD. I have been privileged to benefit from his comprehensive expertise. His
personable support and guidance, along with the invaluable training for the scientific
competitions, have been of irreplaceable help.
I am profoundly grateful to the official referees of this thesis, Docent Anja Siitonen,
PhD, and Docent Matti Viljanen, MD, PhD, for their constructive criticism and valuable
suggestions.
I sincerely thank my co-authors Docent Hannele Jousimies-Somer, PhD, Docent Maria
Saarela, PhD, Dr. Petteri Carlson, MD, PhD, Professor Casey Chen, DDS, PhD, Professor
Satu Alaluusua, DDS, PhD, and Professor Paula Fives-Taylor, PhD, for their collaboration and
sharing their knowledge with me. Professor Pirjo Mäkelä, MD, PhD, is especially recognized
for her advice concerning Study II.
A warm-hearted Merci goes to Québec to Professor Denis Mayrand, PhD, Professor
Daniel Grenier, PhD, Florence Goulhen, MSc, and Pascale Plamondon, MSc, for their kind
help and pleasant collaboration.
I wish to thank Dr. Lianxuan Zhang, MD, for his help in Study IV, and Jaana Mättö,
PhD, Heini Torkko, MSc, and Kirsti Kari, MSc, for their help with the laboratory work. I also
thank Ms. Annikki Sirén for technical assistance. I express my thanks to Carol Norris, PhD,
for revising the language of this thesis.
I warmly thank my mother and father for their support and for always encouraging me
in everything I decide to do. Special thanks go to my sister Heidi for helping me to keep
myself in one piece in the changeable periods of this study.
Finally, I thank everyone for good chemistry and bad chemistry; you cannot create and
develop without both.
This study was financially supported by the University of Helsinki (Scholarship for
Young Researchers), the Finnish Dental Society, and the Finnish Women Dentists’
Association.
Helsinki, January 2000
Susanna Paju
